The QualityStocks Daily Thursday, May 13th, 2021

Today's Top 3 Investment Newsletters

QualityStocks(BICX) $6.0000 +132.56%

MicroCapDaily(SPRV) $0.0150 +35.14%

Tip.us(REFG) $0.0240 +26.32%

The QualityStocks Daily Stock List

Tarena International Inc. (NASDAQ: TEDU)

The Online Investor, MarketClub Analysis, Marketbeat.com, MarketBeat, StreetInsider, Zacks, INO.com Market Report, Street Insider, StockMarketWatch, TradersPro, CRWEPicks, Greenbackers, Investing Futures, CRWEWallStreet, Weekly Wizards, CRWEFinance, BUYINS.NET, BestOtc, DrStockPick, InvestorPlace, Kiplinger Today, Barchart, One Hot Stock, PennyOmega, PennyToBuck, Stock Market Watch, StockHotTips, StreetAuthority Daily, Trading Concepts and Louis Navellier reported earlier on Tarena International Inc. (TEDU), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Tarena International Inc. (NASDAQ: TEDU) (FRA: 0T8A) is a holding company that is engaged in the provision of education services, including non-IT and IT training courses under its brand in China, through its subsidiaries.

The firm has its headquarters in Beijing, the People’s Republic of China and was incorporated in 2002 by Shao Yun Han. It provides its services throughout China. It operates through the kid training segment and the adult training segment. The latter segment offers students an education platform which facilitates online learning modules, classroom-based tutoring and live distance instruction while the former segment offer K-12 education programs, which include robotics programming courses and computer coding. The firm generates most of its revenue from the adult training segment.

The company provides education courses in three other subjects (marketing, online sales and digital art) and seven IT subjects, which include network engineer courses, Python, Web front-end development, Big Data, Linux and network engineering, software testing and Java. Additionally, it also provides an online learning platform for job placement training courses and education courses.

It complements the tutoring and live instruction with Tarena Teaching System, its learning management system. The system has five key functions which include an online student community, student management tools, teaching staff and student interaction tools, self-assessment exams and course content.

The firm recently entered into a merger agreement with Kidedu Holdings Ltd. This merger will not only allow for the expansion of the company but will also bring in more investments.

Tarena International Inc. (TEDU), closed Thursday’s trading session at $3.79, even for the day, on 551,583 volume. The average volume for the last 3 months is 432,565 and the stock's 52-week low/high is $1.50/$3.87599992.

Stealth BioTherapeutics Corp. (NASDAQ: MITO)

StreetInsider, StockMarketWatch, MarketBeat, HotOTC, Trades Of The Day, StockOnion, Profitable Trader Authority, PennyStockScholar, PennyStockProphet, Penny Pick Finders, OTCtipReporter, Daily Trade Alert and Buzz Stocks reported earlier on Stealth BioTherapeutics Corp. (MITO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Stealth BioTherapeutics Corp. (NASDAQ: MITO) (FRA: S1BA) is a clinical stage biotechnology firm that is engaged in discovering, developing and commercializing therapeutics for diseases associated with mitochondrial dysfunction.

The firm’s headquarters are in George Town, the Cayman Islands and was incorporated in 2006, on April 3. It serves consumers in the state of Massachusetts and works with advocacy organizations and patients to raise awareness of these rare genetic ailments and better understand them.

The mitochondria help to generate energy in the body and is necessary for organs to function normally. It is found in almost every cell in the body and is commonly referred to as the cell’s powerhouse.

The company’s product candidates include Elamipretide, which is currently undergoing a phase 3 clinical trial to treat replisome myopathies; a phase 2 clinical trial for the treatment of leber’s hereditary optic neuropathy; phase 2 trial to treat dry age-related macular degeneration; phase 2a trial for the treatment of friedreich’s ataxia; a phase 2/3 clinical trial to treat duchenne cardiomyopathy and a phase 3 trial for the treatment of barth syndrome. It also produces a candidate for rare neurological indications dubbed SBT-550; a candidate indicated for the treatment of complications of diabetes, ALS, Huntington’s, Alzheimer’s, Parkinson’s, neurodegenerative, ocular and renal ailments, dubbed SBT-20.

The firm recently announced the presentation of new data from a ReCLAIM study that evaluated elamipretide’s efficacy in treating patients with dry age-related macular degeneration. The findings confirmed the relationship between mitochondrial health and drug-mediated improvements in visual function, with researchers noting that the candidate not only slowed the progression of the disease but also restored visual quality of life and function. The approval of the candidate as a treatment by the FDA will not only be addressing an unmet need but also boost investments in the firm.

Stealth BioTherapeutics Corp. (MITO), closed Thursday’s trading session at $1.16, off by 7.9365%, on 830,388 volume. The average volume for the last 3 months is 3,891,224 and the stock's 52-week low/high is $1.05999994/$2.57999992.

Reed's Inc. (NASDAQ: REED)

Wall Street Resources, MarketBeat, Stock Guru, QualityStocks, MissionIR, SmarTrend Newsletters, StreetInsider, TraderPower, SmallCap Network, StockMarketWatch, Momentum Traders, The Street, PennyStocks24, Penny Stock Pros, PennyStockClub, PennyTrader.com, Promotion Stock Secrets, StreetAuthority Daily, Stock Traders Chat, Penny Stock Advice, BullRally, BUYINS.NET, InvestorPlace, TradersPro, Tiny Gems, Penny Stocks Expert, Penny Detectives, Zacks, Stock News Now, SmallCapNetwork, StocksImpossible, The Stock Scout, SmallCapVoice, Barchart and OTCBB Journal reported earlier on Reed's Inc. (REED), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Reed's Inc. (NASDAQ: REED) is engaged in the development, manufacture and sale of non-alcoholic beverages, candies and kombucha in South America, Australia, Europe, Asia, Canada and the United States.

The firm has its headquarters in Norwalk, Connecticut and was incorporated in June 1987 by Christopher J. Reed. Prior to its name change in 2001, the firm was known as Original Beverage Corporation.

The company, which operates in the craft specialty foods industry, sells its products to restaurants, on-premise bars, industrial cafeterias, liquor stores, drug and convenience stores, club stores, mass merchants, grocery store chains, gourmet and natural food retailers through independent distributor partners and other distributors, as well as directly. Its products include craft sodas, Reed’s Ginger candy and Flying Cauldron Butterscotch beer.

The enterprise also owns a private label business. This is in addition to manufacturing, licensing, marketing and selling several product lines, such as Real Cola, which includes zero diet sodas; China colas and Culture club kombucha; and Reed’s Ginger brews like Dr. Better, Cream sodas and Virgil’s root beer. It produces these carbonated beverages at different facilities, including one known as The Brewery, which is located in Los Angeles, California.

The company, which has been expanding their distribution across all channels, recently announced that they had gotten into an expanded distribution agreement with CVS Health Corp. This move will allow Virgil’s and Reed’s beverages to be stocked at CVS Pharmacy locations across the U.S. Increased availability is bound to increase sales, which will in turn boost the company’s revenue.

Reed's Inc. (REED), closed Thursday’s trading session at $0.91, off by 2.4129%, on 1,037,308 volume. The average volume for the last 3 months is 2,764,354 and the stock's 52-week low/high is $0.570999979/$1.67999994.

Plus Therapeutics Inc. (NASDAQ: PSTV)

StockMarketWatch, BUYINS.NET, Schaeffer's, MarketBeat, Stock Market Watch, QualityStocks and MarketClub Analysis reported previously on Plus Therapeutics Inc. (PSTV), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Plus Therapeutics Inc. (NASDAQ: PSTV) (FRA: XMPA) is a clinical-stage pharmaceutical firm that is engaged in developing, manufacturing and commercializing new therapies for patients with cancer, as well as other life-threatening ailments, to address unmet market and medical needs.

The firm has its headquarters in Austin, Texas and was incorporated in July 1996 by Christopher J. Calhoun and Ralph E. Holmes. It serves consumers in the states of California and Texas. Before changing its name in July 2019, the firm was known as Cytori Therapeutics Inc.

The company is party to a license agreement with NanoTx Corp. for the development and commercialization of a glioblastoma treatment designed by NanoTx. It provides a nanotechnology platform to better and reformulate chemotherapeutics to offer benefits to clinicians and patients. Its candidate drug products are being developed by a team of physicians, engineers, chemists and biologists, among other professionals.

Plus Therapeutics’ product pipeline includes a generic PEGylated liposomal doxorubicin formulation called DoxoPLUS which is indicated for the treatment of Kaposi’s sarcoma, multiple myeloma, ovarian cancer and breast cancer; a PEGylated liposomal formulation of docetaxel known as DocePLUS indicated for the treatment of solid tumors and small cell lung cancer. The company also develops a patented radiotherapy dubbed Rhenium NanoLiposome, indicated for the treatment of patients with recurrent glioblastoma.

The firm recently entered into a pair of collaboration agreements to support the analytical chemistry activities and process development of its Rhenium NanoLiposome candidate. For new drugs to be brought to the market, appropriate quality controls and process optimization are crucial aspects needed to facilitate this. These agreements bring the company one step closer to commercially supplying their drug to those in need.

Plus Therapeutics Inc. (PSTV), closed Thursday’s trading session at $2.04, off by 5.9908%, on 461,708 volume. The average volume for the last 3 months is 1,325,326 and the stock's 52-week low/high is $1.60000002/$5.42000007.

Precipio Inc. (NASDAQ: PRPO)

StockMarketWatch, MarketClub Analysis, QualityStocks, Profitable Trader Authority, OTCtipReporter, BUYINS.NET, PennyStockScholar, StockOnion, Penny Pick Finders, Buzz Stocks, MarketBeat, Planet Penny Stocks, TradersPro, Schaeffer's, TopPennyStockMovers, PennyStockProphet, PoliticsAndMyPortfolio, Louis Navellier and InvestorsUnderground reported beforehand on Precipio Inc. (PRPO), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Precipio Inc. (NASDAQ: PRPO) (FRA: TGKQ) is a biotechnology firm that is engaged in the provision of diagnostic services and products in the oncology market in the U.S.

The firm has its headquarters in New Haven, Connecticut and was incorporated in 1997, on March 6. It serves consumers in the United States as well as other biotech and pharma companies, physician-office labs, reference labs, hospitals and oncologists.

The company is party to collaboration agreements with the University of Pennsylvania, the Dana-Farber Cancer Institute at Harvard, and the Yale School for Medicine, which specialize in cancer diagnostics, research and treatment. It also operates a cancer diagnostic lab in New Haven and a research and development facility in Omaha, Nebraska.

The firm provides therapies for inherited, neurology, cardiology and oncology ailments. Its services include ICP liquid biopsy testing, HRM kits, SmartGen and SmartPath while its products include IV-Cell, HemeScreen and MX-ICP. Its diagnostic services are focused on diagnosing various blood-related cancers. On the other hand, the HemeScreen panel allows labs and hospitals to run genetic mutation tests while the IV-Cell allows labs to acquire more accurate results. The firm sells ICE-COLD-PCR technology kits and COVID-19 antibody tests to bio-pharma consumers and clinical research institutions.

The company’s coronavirus antibody tests, which had been awarded emergency use authorization by the FDA in December 2020, recently became available on Amazon. While they can only be bought by qualified medics, they still help address a previously unmet need, which will help boost the company’s popularity and in turn, bring in more investors.

Precipio Inc. (PRPO), closed Thursday’s trading session at $3.47, off by 10.567%, on 3,169,361 volume. The average volume for the last 3 months is 12,852,104 and the stock's 52-week low/high is $0.649999976/$9.1800003.

Mastermind, Inc. (MMND)

QualityStocks and SeeThruEquity Research reported earlier on Mastermind, Inc. (MMND), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Mastermind, Inc. is a top involvement marketing agency listed on the OTC Markets’ OTCQB. The Company designs, creates, and activates marketing campaigns for global brands. Mastermind has a complete, data-driven approach. This approach drives brand consideration, trial, loyalty, and advocacy. The Company is a subsidiary of Mastermind Marketing, Inc. A foremost vertically-integrated digital marketing company, Mastermind has its head office in Atlanta, Georgia.

Mastermind has more than three decades of experience in dozens of industries helping involve people with brands in ways that inspire them to take action. The Company’s expertise areas include Content, Digital, Influencer, Social, Promotion, Channel Optimization, as well as Digital Issues Management. This allows Mastermind to create and execute multi-dimensional campaigns that drive results.

The Company has a data-driven process. This involves strategy and planning - objective setting, goal establishment, data and market analysis. Mastermind creates and manages digital content, social media and sharing campaigns, mobile merchandising, and communications and branding programs. Furthermore, the Company designs websites. Mastermind designs, creates, and develops branding and marketing campaigns chiefly for large corporate clients.

Mastermind is creating predictive analytic dashboards to optimize marketing decisions and drive more conversions for Fortune 500 brands. It aggregates and integrates disparate client data sources into custom algorithms to produce unique dashboards, which provide a tailored, on-demand, 360° view of the client’s business.

Last month, Mastermind announced financial results for the Fiscal Year (FY) ended September 30, 2019. Selected results for FY 2019 include Total Revenue of $4.0 million versus Revenue of $5.2 million for Fiscal 2018; Gross Profit of $1.8 million versus $3.2 million for Fiscal 2018; and a Net Loss of $0.8 million versus Net Income of $0.9 million for Fiscal 2018.

Mr. Dan Dodson, Mastermind Chief Executive Officer, said, “Fiscal 2019 brought significant revenue and expense challenges that we were able to successfully navigate. We are confident that 2020 will be a strong year. In FYE 2019, approximately $1.7 million in expected revenue did not materialize due to (1) the merger of a major client, and (2) a surprise bankruptcy filing of another client.”

Mastermind, Inc. (MMND), closed Thursday’s trading session at $0.35, up 33.5878%, on 7,397 volume. The average volume for the last 3 months is 3,740 and the stock's 52-week low/high is $0.05/$0.964600026.

Golden Predator Mining Corp. (NTGSF)

QualityStocks, Small Cap Firm, StockHideout, OTCBB Journal and Broad Street reported previously on Golden Predator Mining Corp. (NTGSF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Golden Predator Mining Corp. acquires and explores for mineral properties in the United States and Canada. It concentrates on its district scale, orogenic gold-in-quartz 3 Aces Project in the Yukon. The Company formerly went by the name Northern Tiger Resources, Inc. It changed its corporate name to Golden Predator Mining Corp. in April 2014. Golden Predator Mining is headquartered in Vancouver, British Columbia and lists on the OTC Markets’ OTCQX.

The 3 Aces Project hosts the two highest grade surface outcrops discovered to date in the Yukon. The 100 percent owned 3 Aces Project is 357 km2 (35,700 hectares). It is a high-grade gold project (Orogenic Gold Model).

The 3 Aces Project includes at least 6 mineralized areas. These are all located within and along favorable stratigraphic and structural zones that extend more than 35km along trend. Several mineralized veins have been discovered so far. Many have visible gold occurrences.

Golden Predator Mining also holds 100 percent of the advanced Brewery Creek Project in the Yukon. The Brewery Creek Mine is operated by the Company. The target at the Brewery Creek Mine is an intrusion related gold deposit. The Brewery Creek Mine is 55km east of Dawson in the northwestern region of the Yukon.

Golden Predator Mining announced previously, the results of its bulk sample program in the Central Core Area at the 3 Aces Project in southeast Yukon, which was completed to test for extensions of the high-grade structures outcropping in the Hearts Zone. Seven HQ diamond drill holes consistently intercepted two parallel, closely spaced gold-bearing structures along 220m of strike and 500m down dip from the Hearts discovery outcrop. This was the deepest drilling so far on the project. The structures in the Hearts Zone continue to be open in all directions along strike and at depth.

Golden Predator Mining reported that roughly 6 percent of the 9,800 metric tonne bulk sample, from the Spades Zone at the 3 Aces Project was successfully processed at the Company-owned test processing plant in Q4 2018. Two concentrates were produced. Number 1 concentrate was poured into a 13,261.5 gram doré bar and shipped to Asahi Refinery in the Province of Ontario. There, it yielded 365 troy ounces of gold (86.28 percent gold) and 34 troy ounces silver (7.63 percent silver) providing a return of $471,386 USD ($623,823 CDN).

Furthermore, 658.1 kilograms (kg) of Number 2 concentrate was recovered and remains in inventory at the plant for ensuing processing. Processing of the bulk sample material uses water and gravity only.

Golden Predator Mining Corp. (NTGSF), closed Thursday’s trading session at $0.16, off by 2.7356%, on 36,096 volume. The average volume for the last 3 months is 129,986 and the stock's 52-week low/high is $0.133000001/$0.365999996.

Future Farm Technologies, Inc. (FFRMF)

CFN Media Group and QualityStocks reported previously on Future Farm Technologies, Inc. (FFRMF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Future Farm Technologies, Inc. is positioned to be a foremost supplier of hemp-derived CBD (cannabidiol) products to meet the increasing demand in the U.S. and worldwide markets. Its experienced management team has a deep understanding of operations and agriculture with the financial and regulatory expertise required to become an industry leader in the changing market for CBD and related compounds. The OTCQB-listed Company previously went by the name Arcturus Growthstar Technologies, Inc. It changed its corporate name to Future Farm Technologies, Inc. in February of 2017. Future Farm Technologies has offices in Vancouver, British Columbia, and Dedham, Massachusetts.

Future Farm current important initiatives are the cultivation and processing of its hemp crop growing in Maine, the pursuit of other hemp-related opportunities across the USA, and the development of elite strains of cannabis in Canada. Future Farm Technologies announced in October of 2019 that hemp from its farm in Hersey, Maine passed the State-mandated testing for acceptable (i.e. below 0.3 percent) levels of THC (Tetrahydrocannabinol). The Company harvested its hemp in October and completed the drying and curing phase of the biomass for extraction and seeds. Both crops achieved yields that outpaced the Company’s apparatus for seed extraction, plant bucking, processing, and also storage.

Future Farm Technologies continues to pursue licenses to grow cannabis for sale, research and development in Canada. It has discontinued projects related to marijuana in the United States to enhance its access to capital and simplify other aspects of business operations. This includes banking and tax planning. It owns a completely operational greenhouse business on about 10-acres in Apopka, Florida known as White Sand Nursery. Currently, White Sand grows ornamental plants that sell in large retail stores throughout North America. In response to the recent passage of the 2018 U.S. Farm Bill, Future Farm decided to expand its existing hemp portfolio to include a partnership in Florida.

The heart of Future Farm Technologies’ breeding and genetics operation are in its relationship with CEPG Consulting and Design, Inc. (CEPG). CEPG is an experienced developer of controlled environment plant growth systems located in St. John’s, Newfoundland.

Future Farm Technologies and High Purity Natural Products, LLC previously announced that on May 27, 2020, the parties had signed a Letter of Intent (LOI) to merge. Subsequently, on July 7, 2020, Future Farm Technologies announced it completed the merger with High Purity Natural Products of Southbridge, Massachusetts, a US leader in advanced contract manufacturing of natural health and wellness products featuring CBD and hand-sanitizer products. Future Farm Technologies was already providing strategic and financial resources to support the quick growth of High Purity’s business. That business includes High Purity’s established operations as a leader in advanced contract manufacturing of health and wellness products featuring CBD and its recent expansion into the hand sanitizer product lines that retailers and other business customers are requiring because of the COVID-19 pandemic.

Future Farm Technologies, Inc. (FFRMF), closed Thursday’s trading session at $0.0598, up 31.4286%, on 146,014 volume. The average volume for the last 3 months is 255,121 and the stock's 52-week low/high is $0.0104/$0.142000004.

Doubleview Capital Corp. (DBLVF)

We reported previously on Doubleview Capital Corp. (DBLVF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Doubleview Capital Corp. is a mineral resource exploration and development company listed on the OTC Markets. The Company identifies, acquires and finances precious and base metal exploration projects in North America, particularly in the Province of British Columbia. It explores for copper, gold, silver, and zinc deposits. The Company’s projects include the Hat Deposit, Red Spring, and Mt. Milligan North. Incorporated in 2008, Doubleview Capital has its corporate headquarters in Vancouver, British Columbia.

The Company’s goal is to aggressively acquire and develop quality and highly prospective mineral projects in mining friendly parts of Canada and specifically in British Columbia. The Hat Gold Rich Porphyry Copper Project situated in Northwest British Columbia (Alkalic Porphyry Deposit type Model) was discovered in 2013/2014 by Doubleview Capital.

Red Spring is located in Northwest British Columbia. It features Copper, Gold, Silver and Zinc. The Mt Milligan North Property is located in Central British Columbia. It is an Alkalic Porphyry Deposit type Model.

Doubleview Capital previously announced the latest assay results from its Hat Gold-Copper Porphyry property positioned in northwestern British Columbia. Core samples from drill holes H026 and H031 extend the Lisle Zone mineralization to the south and at depth with strong gold and copper values and important silver, cobalt, and palladium.

Drill hole H026 was successfully deepened so as to probe what appeared from geophysical data to indicate the vertical continuation of the Lisle Zone. H026 has now extended the Zone to 900 meters from surface. It has confirmed the reliability of the 3D induced polarization survey data. H031 was collared 215 meters south of prior drill holes (550m southwest of drill hole H023) and extended the north-south dimension of the Lisle Deposit to 820 meters. Doubleview Capital completed 2,227 meters drilling in five drill holes. Drill hole H032 was abandoned because of drilling technical issues.

Doubleview Capital Corp. (DBLVF), closed Thursday’s trading session at $0.3998, up 21.1882%, on 670,137 volume. The average volume for the last 3 months is 125,164 and the stock's 52-week low/high is $0.0625/$0.500720024.

BioCorRx, Inc. (BICX)

SmallCapVoice, QualityStocks, PennyStocks24, Fast Money Alerts, Penny Stock General, MassiveStockProfits, OTPicks, Stock Shock and Awe, Equity Observer, MarketBeat, SixFigureStockPicks, Otcstockexchange, Orbit Stocks, Penny Stock Pick Report, PennyPickAlerts, Joe Penny Stocks, Jet-Life Penny Stocks, Liquid Tycoon, Stocks To Watch, Super Hot Penny Stocks, Super Nova Stock Picks, BUYINS.NET, Winning Penny Stock Picks, Shiznit Stocks, WePickPennyStocks, Whisper from Wall Street, Penny Stock Pick Alert, Winston Small Cap, Impressive Penny Stocks, Penny Stock MoneyTrain, Value Penny Stocks, Pennystocktweeters.com, RisingPennyStocks, Center Stage Stocks, MyBestStockAlerts, Market Wire Stocks, Fabulous Penny Stocks, Wall Street Mover, TopPennyStockMovers, PoliticsAndMyPortfolio.com, Pumps and Dumps, AwesomeStocks, POSstocks, Mad Money Picks, HoleinOneStocks.net, SizzlingStockPicks, FOX Penny Stocks, Goldman Small Cap Research, Damn Good Penny Picks, Daily Stock Motion, HEROSTOCKS, Breaking Bulls, PennyStockPickAlert, WallstreetSurfers, ThePUMPTracker, StockRunway, Stock Brain, SmallCapGrowth, Psycho Penny Stocks, Penny Stocks VIP, PennyStocks123, MadMoneyPicks, PennyStockMoneyTrain, PennyStockLaboratory, PennyStockInformer, Penny Stock Newsletter, Penny Picks, Penny Pick Insider and PREPUMP STOCKS reported previously on BioCorRx, Inc. (BICX), and today we report on the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, BioCorRx, Inc. is a leader, developer and provider of advanced solutions in the treatment of addiction and related disorders. The Company offers an inventive approach to the treatment of substance abuse addiction and related disorders. The BioCorRx® Recovery Program is its non-addictive, medication-assisted treatment (MAT) program. BioCorRx is headquartered in Anaheim, California. The Company’s shares trade on the OTC Markets Group’s OTCQB. The Company additionally conducts R&D under its controlled subsidiary, BioCorRx Pharmaceuticals.

A healthcare solutions enterprise, BioCorRx is at the vanguard of alcohol and opioid addiction treatment. Its dedication is on improving the quality of life for recovering addicts. Its recovery program is an outpatient medication-assisted treatment (MAT) program for alcohol and opioid drug addiction.

The BioCorRx® Recovery Program comprises two primary components. The first component consists of an outpatient implant procedure performed by a licensed physician. This implant delivers the non-addictive medicine, naltrexone, an opioid antagonist that can considerably lessen physical cravings for alcohol and opioids. Naltrexone can also prevent opioid overdose following relapse.

The second component of the program is a Cognitive Behavioral Therapy (CBT) program. It is tailored purposely for the treatment of alcoholism and other substance abuse addictions for those receiving long-term naltrexone treatment. The BioCorRx® Recovery Program is used by a network of independently owned and operated treatment centers situated across the U.S.

BioCorRx, Inc. (BICX), closed Thursday’s trading session at $6.00, up 132.5581%, on 20,478 volume. The average volume for the last 3 months is 2,929 and the stock's 52-week low/high is $0.155000001/$9.97999954.

Grizzly Discoveries, Inc. (GZDIF)

QualityStocks, USA Market News, Street Penny Stocks, StockMister, SeriousTraders, PennyStockShark, PennyStocks24 and Information Solutions Group reported previously on Grizzly Discoveries, Inc. (GZDIF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Grizzly Discoveries, Inc. concentrates on developing its precious metals properties in southeastern British Columbia, and significant Potash and Diamond assets in Alberta. The Company primarily explores for gold, silver, copper, lead, zinc, potash, and diamond deposits. OTCQB-listed, Grizzly Discoveries has its head office in Edmonton, Alberta.

A diversified mineral exploration enterprise, the Company holds or has an interest in more than 180,000 acres of precious-base metal and cobalt properties in British Columbia; and metallic and industrial mineral permits for potash totaling over 60,000 acres along the Alberta-Saskatchewan border. In addition, Grizzly has an interest in greater than 161,000 acres of properties that host diamondiferous kimberlites in the Buffalo Head Hills area of Alberta.

Grizzly Discoveries entered into a Letter of Intent (LOI) with a private group to purchase the Cobalt-Copper-Silver "Robocop Property", positioned within the Fort Steele Mining District in southeastern British Columbia. The Robocop Property is roughly 45 kilometers (km) south of Fernie and 70 km southeast of Cranbrook. The Property is immediately north of the Canada-U.S. border.

The Property comprises 5 mineral claims totalling 9,891 acres. The Robocop Property is east of Grizzly Discoveries’ Greenwood Property in southeastern British Columbia. Grizzly Discoveries has started exploration activities at its earlier acquired Robocop property by mobilization of a field crew in advance of an airborne geological survey.

Concerning Greenwood, Kinross undertook a planned 1,200 m drill program at the Midway area during July and August 2018, to continue the proof of concept drilling at the Midway Epithermal Target intersected in 2017. Proof-of-concept drilling in 2017 intersected silicification, alteration, anomalous geochemistry, and minor quartz veining in 2 out of 3 holes along strike, warranting more follow-up exploration.

This week, Grizzly Discoveries announced that it was advised by Kinross Gold Corporation's wholly owned subsidiary, KG Exploration (Canada) Inc. that it completed its 2018 work program on the Grizzly Greenwood property near Greenwood in southern B.C. The 2018 work program, via drilling, confirmed the presence of extensive epithermal alteration at the Midway target area.

The portions of Grizzly Discoveries’ Greenwood Project undergoing exploration by Kinross is 100 percent owned by Grizzly Discoveries, Inc. and includes 131 claims, which form a contiguous package totaling around 27,346 hectares, representing about one third of Grizzly's land holdings at Greenwood.

With the agreement, KG Exploration (Canada) Inc. can earn a 75 percent interest on the optioned land pursuant to an Option Agreement with Grizzly Discoveries on portions of its land holdings in southeastern British Columbia, through incurring US$3 million in exploration expenditures over a 5 year period. KG Exploration (Canada) Inc. has incurred roughly CDN$1,280,500 in exploration expenditures so far.

Grizzly Discoveries, Inc. (GZDIF), closed Thursday’s trading session at $0.058, up 23.4043%, on 295,900 volume. The average volume for the last 3 months is 85,731 and the stock's 52-week low/high is $0.0302/$0.068999998.

Integrated BioPharma, Inc. (INBP)

MarketBeat, QualityStocks, Zacks, The Stock Psycho, AllPennyStocks, Wall Street Mover, Top Gun, StockMister, OTCPicks and HotShotStocks reported previously on Integrated BioPharma, Inc. (INBP), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Integrated BioPharma, Inc. engages primarily in the manufacture, distribution, marketing, and sales of vitamins, nutritional supplements, and herbal products. Its customers are mainly in the United States, Luxembourg, and Canada. Integrated BioPharma develops, manufactures, and distributes, around the world, in excess of 130 products. The Company does so through several wholly-owned subsidiaries.

Integrated BioPharma formerly went by the name Integrated Health Technologies, Inc. Established in 1979, the Company is based in Hillside, New Jersey. Integrated BioPharma lists on the OTC Markets.

Integrated Biopharma’s companies include AgroLabs, Inc., Chem International, IHT Health Products, Inc., Manhattan Drug Company, and Vitamin Factory. Integrated BioPharma operates via three segments. These are Contract Manufacturing, Branded Proprietary Products, and Other Nutraceutical Businesses.

AgroLabs manufactures and markets healthful nutritional products under the Naturally Noni, Naturally Pomegranate, Naturally Aloe, and Naturally Mangosteen brands. Additionally, AgroLabs distributes internationally, in Canada, Germany, Japan, Korea, Mexico, Taiwan and the United Kingdom (UK). Integrated BioPharma’s Chem International offers a broad assortment of Roche Vitamins' food and cosmetic products.

The Company’s Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. Its Branded Proprietary Products segment distributes healthful nutritional products for sale through mass market, grocery, drug, as well as vitamin retailers.

The Other Nutraceutical Businesses segment sells private label vitamin and nutritional supplement products, and healthful nutritional products through the Internet. In addition, this segment distributes fine natural botanicals. This includes multi minerals and raw materials. Moreover, the Other Nutraceutical Businesses segment provides warehousing and fulfilment services.

Integrated BioPharma’s Vitamin Factory sells nutritional supplements directly to the consumer by way of mail order catalogs and over the Internet. Vitamin Factory’s product categories are dietary supplements, liquid items, sports supplements, and skincare supplements.

Manhattan Drug Company provides vitamins and nutritional formulations. It engages in the manufacturing of tablets, capsules, or blends; packaging and labeling in bulk; help in product registration worldwide, and distribution of finished product. Also, Manhattan Drug Company engages in analytical and microbiological testing via its in-house laboratories.

Integrated Biopharma’s IHT Health Products sells and distributes fine chemicals. These include science-based proprietary products and value added formulations. IHT sells and distributes these to the nutritional, pharmaceutical, food, and cosmetic industries. IHT products include vitamins, amino acids, herbal extracts, Over-the-Counter (OTC) pharmaceuticals, excipients, and unique patented products.

Integrated BioPharma, Inc. (INBP), closed Thursday’s trading session at $1.18, up 20.4082%, on 34,170 volume. The average volume for the last 3 months is 13,401 and the stock's 52-week low/high is $0.264999985/$1.25.

Featured Whitepapers

A Case for Small & Micro-Cap Investing

Avenel Financial Group’s (AFG) financial research analysts and interns researched the top performing Microcap investors, studied their investments, and analyzed quantitative and qualitative metrics along with the historical performance of this asset class.

Read More...

Featured Whitepaper

XPEL Case Study

Did You Miss Your Opportunity on This 100-Bagger?

As a continuation of our study of Super Compounders we will evaluate one of the more prominent 100-Baggers of the past decade. XPEL technologies is a company that has rose to dominate the niche space of protective films for car paint and has rapidly grown through intelligent capital allocation and acquisitions. Paul Andreola of Smallcap Discoveries first brought this to MicroCapClub in 2013. Attached is an in-depth analysis of its meteoric rise, which we hope will help you to spot the next 100-Bagger.

Read More...

Featured Whitepaper

Quality Shareholders

Lawrence A. Cunningham discussed the makeup of the modern shareholder group in his recent book “Quality Shareholders.” In this paper we briefly discuss the primary takeaways and applications of the concepts in this book and the advantages inherent in the active cultivation of a quality, engaged shareholder cohort. The insights in Cunningham’s book are impactful and may illuminate new strategies for evaluating a firms management.

Managers get the shareholders they deserve.” – Lawrence Cunningham

Read More...

 

The QualityStocks Company Corner

Pressure BioSciences Inc. (PBIO)

The QualityStocks Daily Newsletter would like to spotlight Pressure BioSciences Inc. (PBIO).

Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform solutions to the worldwide life sciences and other industries, today announced the award of three additional patents for its revolutionary Ultra Shear Technology™ (UST™) platform, all entitled "System for High Pressure, High Shear Processing of Fluids". The new patents, awarded in Japan (No. 6843063), Australia (No. 2016243553), and China (ZL201680026865.2), bring the Company's Intellectual Property ("IP") estate to a total of 6 issued patents for UST and 29 issued patents overall.

Pressure BioSciences Inc. (PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.

The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.

Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”

Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.

The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.

Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.

This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions — all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.

The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.

Pressure BioSciences Inc. (PBIO), closed Thursday’s trading session at $1.80, up 2.8571%, on 9,486 volume. The average volume for the last 3 months is 12,493 and the stock's 52-week low/high is $1.28999996/$3.95000004.

Recent News

The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER)

The QualityStocks Daily Newsletter would like to spotlight The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER).

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER)a producer of premium bottled alkaline water, flavor-infused waters and CBD-infused products sold under the brand names Alkaline88(R), A88 Infused(TM), and A88CBD(TM), is partnering with Shaquille O’Neal, who will be joining the company as an equity partner and member of the Company’s Board of Advisors. In addition, O’Neal will serve as a marquee brand ambassador for Alkaline88, a brand recognized for its high-quality hydration and perfect 8.8pH balance. Developed to deliver a smooth taste that encourages consumers to drink more, Alkaline88 also represents WTER’s dedication to purity, quality and value. Alkaline88 ionized water contains just two ingredients: water and Pink Himalayan Rock Salt. “Shaquille O’Neal’s track record as a basketball champion and Hall of Famer has translated into similar successes in business and corporate partnerships,” said The Alkaline Water Company chair Aaron Keay in the press release. “His reputation as an astute investor, larger-than-life brand partner, and phenomenal ambassador makes this partnership extremely exciting. We want to welcome Shaquille to the Company’s advisory board and believe his positive presence and global outreach will enable Alkaline88(R)to aggressively push our growth trajectory even faster.” To view the full press release, visit https://ibn.fm/XDmdv

Founded in 2012, The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) is headquartered in Scottsdale, Arizona. Its flagship product, Alkaline88®, is a leading premier alkaline water brand available in bulk and single-serve sizes, along with eco-friendly aluminum packaging options. With its innovative, state-of-the-art proprietary electrolysis process, Alkaline88® delivers perfect 8.8 pH balanced alkaline drinking water with trace minerals and electrolytes and boasts the company’s trademarked label ‘Clean Beverage’. Quickly being recognized as a growing lifestyle brand, Alkaline88® launched A88 Infused™ in 2019 to meet consumer demand for flavor-infused products. A88 Infused™ flavored water is available in six unique all-natural flavors, with new flavors coming soon. Additionally, in 2020, the company launched the A88CBD™ brand, featuring a broad line of topical and ingestible products. These products are made with lab-tested full and broad-spectrum hemp and include salves, balms, lotions, essential oils, bath-salts, CBD infused drinks, tinctures, capsules, gummies and powder packs.

Innovation and Expansion

Founded in 2012, The Alkaline Water Company began with a mission to create the best-tasting water in the world. At the time, there were two emerging trends in health-conscious consumers: a growing interest in the alkaline diet and perceived health benefits of pink Himalayan rock salt. By combining these two concepts in an alkaline water and trademarking the name Alkaline88, The Alkaline Water Company began offering what it calls the smoothest tasting Clean Beverage™ in the U.S. enhanced-water category.

Now a top bulk alkaline-water brand (the company reported record sales in March and April 2020, surpassing March and April 2019 numbers by 114% and 171%, respectively), The Alkaline Water Company is committed to growing its national footprint through innovation and expansion. That mindset was evident as the company introduced eco-friendly aluminum bottles and branched out into flavor-infused waters; the company currently offers six different flavors: peach/mango, lemon/lime, raspberry, watermelon, blood orange and lemon.

The company’s commitment to innovation may be most evident in its newest product line: A88CBD. This line of CBD-infused products includes tinctures, capsules, gummies, salves, balms, hand and foot lotions, essential oils, bath bombs and bath salts, as well as CBD-infused drinks, water and beverage shots. These quality, CBD-infused offerings are all made with lab-tested, full-spectrum hemp and are conveniently packaged and perfect for on-the-go or at home use.

In addition, The Alkaline Water Company has implemented an aggressive growth strategy, with numerous organic initiatives focused on national multichannel, mass-market expansion through a direct-to-warehouse model and co-packing facilities that are strategically located within 600 miles of 95% of the U.S. population. In addition to this strong brick-and-mortar approach, the company recently launched a B2C e-commerce platform (www.A88CBD.com) and aggressive digital-marketing campaigns.

Clear Advantages in a Growing Market

With consistent growth year over year, the company reported $32.2 million in revenue in fiscal 2019 and has emerged as a growth leader in the functional (value-added) waters space, which is the fastest-growing segment of the bottled water industry.

The Alkaline Water Company’s efforts are focused on its clear competitive advantages, including its strong marketing (the inclusion of alkaline in product names); existing grocery channels, which feature excellent relationships and a nationwide broker network; distinctive branding; proprietary technology, which produces great-tasting, high-quality water, infused drinks and other products; and price, with a broad range of products in all formats, from bulk bottles to single serve.

As the company focuses on strategic growth, it is eyeing the impressive potential of a market that is on a strong upswing. Annual bottled water sales have now surpassed soda consumption, with soda sales in the United States having declined by $1.2 billion over the past five years. Some research indicates that the global bottled water market will reach an estimated $280 billion this year, while the CBD market is forecast to top $20 billion by 2024.

With its products available in all major trade channels, including grocery stores, drug stores, c-stores and big-box retailers, The Alkaline Water Company is also looking to expand into new spaces, such as health and beauty, hospitality and specialty retailer locations.

Seasoned Management Team

The Alkaline Water Company is led by an experienced team focused on the company’s core strategy of building a national retail footprint and extending its lifestyle brands into other consumer packaged goods categories.

Richard A. Wright, President, CEO and Co-Founder of The Alkaline Water Company Inc., oversees all aspects of the business, successfully guiding the company through strategic opportunities and delivering greater than 50% growth since the company’s inception. A passionate and versatile leader with a strong track record of innovation, collaboration and achieving goal-driven results, Wright is a serial entrepreneur with more than 41 years of experience. Early in his career, he spent years at one of the ‘Big Four’ accounting firms, working his way up to Regional Director of Tax and Financial Planning. As a CPA, entrepreneur and former CFO, Wright brings extensive knowledge of finance, operations, sales and marketing to the team, and he has participated in hundreds of M&A transactions throughout his career.

David Guarino, CFO, Secretary, Treasurer and Director, earned a Bachelor of Science in accounting and a Master of Accountancy from the University of Denver. From 2008 to 2013, Guarino was President and a Director of Kahala Corp., a worldwide franchisor of multiple quick-service restaurant brands with locations in 49 states and more than 25 countries. From 2014 to 2015, Guarino was President of HTI International Holdings Inc., a technology company focused on forward osmosis water filtration technology.

Frank Chessman, National Sales Manager, is a graduate of the University of Southern California’s Marshall School of Business. He spent 25 years with Ralph’s Grocery, Kroger’s largest division, working at many levels before ultimately becoming Vice President of Advertising & Marketing. He then served 14 years as Executive Vice President at Simon Marketing. Chessman has more than a decade of experience in the beverage manufacturing industry.

Brian Sudano, Director, is managing partner of Beverage Marketing Corporation and BMC Strategic Associates. Sudano’s experience covers nearly the entire beverage industry, from energy drinks to wine, with special expertise in beverage alcohol by virtue of varied industry experience across a broad range of projects. Sudano manages several major clients, providing ongoing strategic and market advice and leading projects in strategic planning, market entry analysis and planning, sales/distribution, business modeling, brand repositioning and international opportunity assessment. He has spoken at many beverage industry events and is a contributing editor at Beverage World magazine.

Aaron Keay, Chairman, has been a successful investor, entrepreneur and financier to multiple small cap and startup companies over the last decade. During his time with these companies, he served in advisor, board-member and senior-management roles. His experience ranges across multiple sectors in mining, biotech, health and wellness, tech and cannabis, where he has invested and raised more than $500 million.

The Alkaline Water Company Inc. (NASDAQ: WTER), closed Thursday’s trading session at $1.03, up 3.00%, on 2,060,335 volume. The average volume for the last 3 months is 1,257,883 and the stock's 52-week low/high is $0.870000004/$2.5999999.

Recent News

Mobius Interactive Ltd.

The QualityStocks Daily Newsletter would like to spotlight Mobius Interactive Ltd..

Mobius Interactive, an online esports and gaming operator, is expanding into the Brazilian market. The company announced that Mobius.Bet ads will be displayed prominently in every stadium for all eight World Cup qualifiers in Latin America; the stadiums have capacities that range from 38,755 to 78,838. In addition, the brand will be displayed on Globo TV while the matches are being broadcast. A soccer powerhouse, Brazil holds more World Cup victories than any other team and have qualified for every World Cup they have entered. The announcement noted that there will be an estimated 35 to 40 million viewers per match being exposed to the Mobius.Bet brand; the match against Argentina, Brazil’s biggest rival, alone is expected to draw more than 40 million viewers. “As we go to market in Brazil with this great opportunity, Mobius.Bet will be showcased on Globo TV and in every stadium, featuring the best teams in Latin America,” said Mobius Interactive CEO Lynn Pearce in the announcement. “I don’t believe we could have wished for a better launch pad to introduce ourselves to the sports enthusiasts and betting community in this region. The team at Mobius are ecstatic to be a part of these events; we are just as excited about the games as the fans are – all the way to Qatar in 2022.To view the full announcement, visit https://ibn.fm/EBwxS

Mobius Interactive Ltd. is an online gaming operator launching in September 2020 with a variety of unique offerings catering to diverse demographic groups. In partnership with Ultra Play, a leading eSports and iGaming platform, Mobius Interactive is seeking to attract a network of high-net-worth gamers from around the world through the use of loyalty and gamification programs designed to enhance customer engagement by leveraging state-of-the-art customer relationship management systems and joint-ventures with over 600 VIP and Master gaming affiliates.

Array of Brands

Mobius Interactive is seeking to target a variety of customer segments and geographies through its diverse brand offerings, including:

  • Aragon Casino: Austria, Finland, the Balkans, Canada, Africa and New Zealand
    Catering to consumers aged 21 to 45, Aragon Casino brands itself along the lines of medieval fantasy, mimicking elements from the likes of The Walking Dead and Game of Thrones.
  • Club Double: Austria, India, Brazil, Finland, Canada, Africa and New Zealand
    Targeting the 30 to 65 age demographic, Club Double is designed to exude a classic yet magical old Hollywood and vintage Miami & Las Vegas air.
  • MobiusBet: Germany, Austria, Switzerland, Brazil, Latin America, New Zealand and India
    MobiusBet is designed to appeal to the 18- to 38-year-old eSports community, bringing together loyalty programs, targeted gamification and product merchandising in one seamless package.

Key Differentiating Indicators

Mobius Interactive has designed its platform with a number of key differentiation traits relative to its target market. These include:

  • The use of affiliates: Mobius Interactive has partnered with over 600 VIP and Master gaming affiliates, who will introduce high-value players to the company’s award-winning iGaming platform. Mobius added over 150 proven affiliates in Europe, Brazil, Finland and New Zealand over a period of just 20 days.
  • eSports Focus: Mobius.Bet, Mobius Interactive’s dedicated eSports hub, will cater to the quickly growing eSports segment, which is expected to rise to a value of $1.7 billion in 2021. With Mobius’ COO being one of the original founders of the eSports.com brand, the company aims to capitalize on this growing segment of the gaming industry.
  • Customer Relationship Management (CRM): Mobius has partnered with Solitics, a new and real-time CRM system, enabling the company to personalize customers’ gaming experiences in an interactive and highly intelligent manner.
  • Loyalty & Gamification: Mobius Interactive is set to introduce a unique loyalty and gamification program designed to increase customer engagement from signup. Loyalty and gamification programs have been proven to increase daily active wagering volumes by 30% while simultaneously increasing daily player activity by 60%. Furthermore, the introduction of these programs can help lower the company’s customer acquisition costs while adding a differentiating element to its platform.

Partnership with Puurl

Puurl provides a solution that embeds eGaming platforms into any existing online e-commerce store. First, shoppers can install the Puurl add-on to their browsers. Then, when visiting their preferred e-commerce stores, players will be prompted to bet, with the potential to win the products they’re browsing. The Puurl solution enables e-commerce operators and eGaming platforms to earn additional gambling revenues – even when their players are shopping. Through its partnership with Puurl, Mobius Interactive will look to add a unique revenue stream to complement its core business operations.

Management Team

Lynn Pearce, CEO, is an experienced, data-driven, commercially focused, strategic brand marketer with over 15 years of proven success in the global gaming industry, from land-based casinos in the UK to online gaming companies offering sports betting, poker and casino games. She was head-hunted to join a startup in Prague that launched 26 casinos, becoming profitable within the first three months of operation, before she relocated to Malta to join a leading B2B casino software development company as head of marketing, where she led global marketing, PR, product development, branding and go-to-market campaigns, retaining full control of a six-month budget of €1 million to increase brand awareness and customer engagement. She recently returned to the B2C side of gaming to launch three new brands in Germany, Brazil and India. She writes articles regularly for Infinity Gaming Magazine and has been a judge for the prestigious International Gaming Awards, a significant event for the gaming industry held each year prior to the largest gaming exhibition of the year, ICE London.

Robin Lawson, Vice President & COO, has been involved in iGaming for over 10 years, successfully founding two VIP casino departments across international locations in Latin America, as well as startup company Tabella in Europe. He most recently co-founded and acted as COO for eSports.com, which raised over $5.5 million as a startup ICO and was sold to German media giant ProSieben. Lawson is also a senior iGaming consultant for startup casino groups and an advisor to blockchain-based tech groups. His long-time experience and proven track record in startup organizations demonstrate his operational leadership skills.

Nicholas de Freitas, Vice President, Marketing, is one of the pioneers of digital stills photography for major retail companies in Africa and Australia. He left to start up UrbanActive, an outsourcing agency, working as marketing project manager and implementing major retail projects. He received his certification in digital marketing from the University of Stellenbosch. He has worked over the past few years as the marketing manager for various poker rooms and casinos, liaising and building relationships with software developers, successfully implementing a number of casino and poker products and holding regular weekly report sessions with the heads of all divisions of the company, spanning South Africa, Canada, Malta, Norway and Costa Rica.

Gary Eldridge, Chairman, is an experienced entrepreneur with a history of working in the venture capital and private equity industry. He is skilled in capital markets, M&A and funding startups and is a strong business development professional. For the past 30 years, he has created and managed numerous public and private companies in Canada, the U.S., Amsterdam, London, Zurich, Dusseldorf, Singapore and Panama. In addition to holding the role of chairman of the company, Eldridge is acting as a mentor to the team, assisting with the financials and structure of the company while allowing the team to be fully focused on Mobius’ growth and operations.

Recent News

chart

FingerMotion Inc. (OTCQX: FNGR)

The QualityStocks Daily Newsletter would like to spotlight FingerMotion Inc. (OTCQX: FNGR) .

FingerMotion (OTCQX: FNGR) has leveraged its relationship with the three largest telecommunication companies in China and has, as a result, grown its big data division. “This division comprises a team of data scientists and actuaries who have developed proprietary algorithms to predict human behavior,” reads a recent article. FNGR then tests and refines these algorithms using platforms provided by the telecommunication juggernauts, which have a combined subscriber base of over 1.5 million users. “FingerMotion, which intends to ultimately offer products for the insurance, health care and finance sectors, is initially focusing on insurtech. This focus was evident in January when the company announced it has partnered with Pacific Life Re-insurance, in effect becoming its data provider. Notably, the partnership will extend beyond simply providing data as FNGR will also offer behavioral analytics, which Shen [FingerMotion CEO] described as ‘brief insights into human nature itself.’” To view the full article, visit https://ibn.fm/h51HE

FingerMotion Inc. (OTCQX: FNGR) is an evolving technological company with core competencies in mobile payment and recharge platform solutions in China. FingerMotion is in the process of developing additional value-added technologies to market to users.

Founded in 2016, FingerMotion’s goal is to serve over a billion users in the Chinese market and expand its model to other regional markets. The company has offices in Hong Kong, Shanghai and New York City.

Current Offerings

FingerMotion is analyzing and transforming mobile data to improve the lifestyle of the public through technology and innovation. The company’s current offerings include:

  • Telecommunications Products and Services – FingerMotion’s proprietary universal exchange platform, ‘PigeonHole Integration System (PIS)’, offers seamless integration between telecom operators and online stores. The service platform’s offerings include top up and recharge, data plan, mobile phone, loyalty points redemption and subscription plans. The platform offers reliable and secure transactions, real-time reconciliation, simple integration for partners and efficient settlements.
  • SMS and MMS Services – The integrated platform is registered as FingerMotion’s IP in China and provides a robust back-end control panel for corporate partners to manage their own messaging settings. FingerMotion’s clients range from insurance to financial industries, ecommerce firms, airlines and more. The platform offers competitive pricing for partners and provides quick and efficient review to meet timely marketing initiatives.
  • Big Data Insights – FingerMotion brings Big Data-enabled insurance solutions through its Big Data Insights arm, Sapientus. The company’s strategic partnerships with the largest Chinese telecommunications giants allow access to uncover behavior insights through geolocation and mobile data usage. Its Big Data offerings include risk scoring, precise marketing, simplified underwriting and customized products.
  • Rich Communication Services (RCS) – FingerMotion’s RCS platform will be a proprietary business messaging solution that enables businesses and brands to communicate their services to customers via 5G infrastructure. The company expects its RCS platform to offer a better user experience, more efficiency and cost-effectiveness when compared to other solutions.

Telecommunications and Insurtech Markets

The global telecommunications market was valued at $1.74 trillion in 2019 and is expected to grow at a CAGR of 5% from 2020 to 2027. The steady increase is expected to be driven by the adoption of 5G and the increased popularity of Internet of Things (IoT) applications.

The Chinese telecom market was valued at $254.1 billion in 2017 and is also constantly expanding. The current Chinese telecom market is dominated by three mobile operators – China Mobile, China Unicom and China Telecom, which together are responsible for around 1.6 billion active subscribers (https://ibn.fm/zfwy9).

In addition, the insurtech (insurance technology) market was valued at $2.72 billion globally in 2020 and is expected to grow at a CAGR of 48.8% from 2021 to 2028. The large increase is attributed to the rising use of technology solutions for everyday activities like acquiring insurance coverage (https://ibn.fm/TGo7D).

Through its proprietary platforms and technologies, FingerMotion is uniquely positioned to capitalize on the telecom and insurtech markets’ growth and opportunities.

Management Team

Martin J. Shen is the Chief Executive Officer of FingerMotion Inc. He has over 15 years of experience in senior management roles within entrepreneurial startups and large multinational corporations. He has acquired a wide range of corporate management, financial oversight and operation administration expertise through these roles. In his most recent role, he founded Imperial Distributors (formerly known as AP Martin Pharmaceutical Supplies Ltd.), establishing the company as the preferred choice for distributional support to regional pharmacies throughout Western Canada. Before founding Imperial, Mr. Shen served as the Chief Operating Officer and Chief Financial Officer at Wales and Son Industrial (formerly Weir Minerals), a firm specializing in global delivery and support for mining slurry equipment. He began his career at PricewaterhouseCoopers in Vancouver, with work tours in the tax department in Singapore and the tax audit and advisory group in Hong Kong. Mr. Shen is a U.S. Certified Public Accountant and holds a Bachelor of Science from the University of British Columbia.

Lee Yew Hon is the company’s Chief Financial Officer. From 2006 until November 2020, he was the Chief Financial Officer of Cubinet Interactive Group of Companies, and he also took on the Chief Operating Officer role in 2011. During his tenure, he was instrumental in leading Cubinet and building teams across the Southeast Asia region, setting up financial processes within a short time. Mr. Lee spearheaded the growth of Cubinet to other regions, including Europe, the Middle East and Russia. He received his diploma from Tunku Abdul Rahman College in 1996. He is a Chartered Accountant, a member of the Malaysia Institute of Accountants (MIA) and an Associate Member of the Chartered Institute of Management Accountants, UK (ACMA).

Li Li is the Senior Vice President of FingerMotion. She recently served as Advisor to Shenzhen WuYiKa Technology Co. Ltd., a comprehensive service platform dedicated to online service distribution and payment. The company has become a fast and efficient provider of new media marketing solutions for the mobile internet. She has held high-level management positions with multiple industry names, including Hangzhou JiuYue Information Technology Co. Ltd. and Hangzhou LingXuan Information Technology. Ms. Li started her career in 2004, founding Shanghai ChuangYeZZ Network Technology Co. Ltd. and serving as its Vice President. With the close cooperation of local operators, the company launched SMS, MMS, WAP, mobile JAVA games, Hunan Satellite TV e-magazine and other wireless internet services to meet the rapid development of wireless internet and application requirements. She received her degree from Nanjing Academy of Engineering.

FingerMotion Inc. (FNGR), closed Thursday’s trading session at $7.75, off by 4.908%, on 6,269 volume. The average volume for the last 3 months is 14,145 and the stock's 52-week low/high is $0.25/$17.00.

Recent News

Ideanomics Inc. (NASDAQ: IDEX)

The QualityStocks Daily Newsletter would like to spotlight Ideanomics Inc. (NASDAQ: IDEX).

Ideanomics (NASDAQ: IDEX) today announced its entry into a definitive agreement to acquire 100% of privately held US Hybrid in cash and stock consideration, the material terms of which are disclosed in the company's related 8-K filing. The acquisition, subject to customary closing conditions, brings to Ideanomics the application of U.S.-built technology, for use in its own vehicles, and significantly extends the company's capabilities in zero-emission transportation. "The acquisition of US Hybrid is a significant one for our EV efforts across the Ideanomics Mobility division and is the stepping-stone we were looking for to ensure we provide vehicles and technologies that can proudly allow us to state the meaningful components are Made in America," said Alf Poor, Ideanomics CEO. "We will be bringing their technologies and capabilities into our own vehicles, as well as helping the broader industry leverage the outstanding technology the US Hybrid team has developed in Hybrid, EV and Hydrogen fuel cells. With decades of experience and credibility from deployments with reputable customers, US Hybrid will become an innovation engine for Ideanomics and provide strategic opportunities for clean technology applications across the zero-emissions transportation value chain, both now and in the future." To view the full press release, visit https://ibn.fm/4BgOc. Also, the company announced that Vince Graziani, Chief Executive Officer, and James A. Simms, Chief Financial Officer, will present at the Needham 16 th Annual Technology & Media Conference, which will be held as a virtual event. Management is scheduled to present on Tuesday, May 18, 2021 at 3:45 P.M. ET and will be available throughout the day to meet with investors participating at the conference.

Ideanomics Inc. (NASDAQ: IDEX) is a global company facilitating the adoption of commercial electric vehicles and supporting next-generation financial services and fintech products. Ideanomics is currently divided into two divisions – mobility and capital. These divisions provide shareholders with access to disruptive and high-growth opportunities.

The company expects 2021 to be another growth year after it raised approximately $400 million over the past six months. This funding has already been put to good use with acquisitions of Wireless Advanced Vehicle Electrification (WAVE) and Timios. With roughly $200 million still on the balance sheet, Ideanomics continues to look for new investments and acquisitions in revenue-based opportunities focused on EV and fintech businesses.

Founded in 2004, Ideanomics is headquartered in New York, New York, with additional offices in Hangzhou, Beijing and Qingdao, China. Its current operations span the United States, China, Ukraine and Malaysia.

Ideanomics Mobility

Ideanomics Mobility is focused on the EV market. The global commercial EV market was valued at $34.7 billion in 2018 and is expected to grow at a CAGR of 39.9% through 2022 to reach a total of $132.73 billion (https://ibn.fm/pPrf4). According to a survey by Grand View Research, the global EV charging infrastructure market is also expected to grow and reach $144.97 billion in 2028, expanding at a CAGR of 33.4% from 2021 to 2028.

This growth is expected to be driven by increased support of electric vehicles from the public, as well as the current U.S. administration, which has a goal of achieving a 100% clean-energy economy.

The Ideanomics Mobility unit consists of five companies:

  • Mobile Energy Global (MEG) – Wholly owned China-based service provider of the Sales-to-Finance-to-Charging (S2F2C) business model to assist commercial fleet operators on EV enablement. Recent sales include 2,000 units of D1, BYD’s custom electric ride-hailing vehicle.
  • Medici Motor Works – Wholly owned North America division. MMW will develop zero-emissions specialty vehicles, trucks, buses and vans for the North American market.
  • Wireless Advanced Vehicle Electrification (WAVE) – Wholly owned Utah-based commercial EV charging technology company with a specialized offering of in-ground wireless charging for commercial vehicles. WAVE’s chargers power the Antelope Valley Transportation Authority, the largest municipal EV bus system in the country. Its revenue for 2020 exceeded $7 million, and it boasts a robust pipeline for 2021 and beyond.
  • Treeletrik – Majority investment in Malaysian-based OEM will service a high-demand market – electric delivery mopeds. Treeletrik has obtained certifications in Thailand and Indonesia, with orders secured for 2021. Its North American marketing program is expected to commence in 2021. As a part of the ESG initiative, one tree will be planted for every unit sold.
  • Solectrac – Minority investment in California-based electric tractor company. Solectrac manufactures 100% electric tractors to benefit farmers, crops and the planet at a time when the agriculture market remains virtually unaddressed by EV solutions.
  • Silk EV – Minority investment in hyper car and performance car design company, which provides access to the high-end battery and charging technology development ecosystem.

Ideanomics is generating EV revenue from its Sales to Financing to Charging (S2F2C) business model, which features three operating areas:

  1. Vehicle and Battery Sales: Medici, Treeletrik and Solectrac cover three key market segments
  2. Financing, Leasing and Insurance: Offering financial services to fleet customers, commission delivery and origination fee-based revenue
  3. Charging and Energy Services: Offering charging as a service, battery swap programs and WAVE wireless charging products

Ideanomics Capital

Ideanomics Capital is focused on providing disruptive fintech solutions across the entire board of financial services, ranging from financial markets to digital securities and assets to mortgages and more. More mainstream institutions and a growing number of companies have increased their digital securities services, along with institutional investments boosting bitcoin and the emergence of favorable regulatory developments, creating ample opportunities for widespread adoption of financial technologies.

Additionally, the U.S. real estate industry is ripe for technologization, as it currently is fragmented, antiquated, opaque and largely untouched by tech innovation. However, the expanding market, with U.S. home sales expected to grow 21.9% in 2021, and the increased digitization of all business spaces are expected to promote a digital-first experience as the new industry standard this year and beyond (https://ibn.fm/DwsUv).

The Ideanomics Capital unit consists of five companies:

  • Timios – Wholly owned subsidiary bringing real estate into the 21st century by providing value-add, fee-based services addressing the title and closing process of home buying and mortgage transactions. Timios works to create transparency and efficiency within the market. Timios ended 2020 as a cash flow and EBITDA positive business.
  • The Delaware Board of Trade (DBOT) – Wholly owned FINRA-regulated ATS and broker dealer based in Delaware.
  • Liquefy – Minority investment bringing innovation to investment in real assets with blockchain technology by increasing efficiency in fractional ownership, lowering entry to investment barriers and unlocking liquidity in assets that were previously illiquid.
  • Technology Metals Market (TM2) – Minority investment in UK company delivering a direct investment and trading market for technology metals with a newly accessible technology metals asset class for inventory diversification. The traded metals are 100% backed by physical metals.
  • Intelligenta – Investment providing AI and machine learning solutions for financial institutions and regulators.

Management Team

Alf Poor is Ideanomics’ Chief Executive Officer. He is a client-focused and profit-driven executive who has a track record of success in rapidly growing technology companies and large, multi-national organizations. Mr. Poor’s expertise includes business planning, financing and creating and implementing corporate governance policies, as well as handling management across organizations. His specialization is working with cross-border and multi-national startups. Before taking the CEO role at Ideanomics, he was the CEO for Global Data Sentinel.

Conor McCarthy is the company’s Chief Financial Officer. He is a strategic and operationally oriented management-level professional. His extensive international experience is within the fintech, data science and advertising technology sectors. Mr. McCarthy has experience with public companies, PE, and VC-backed firms. His specializations are financial and management reporting, planning and analysis, financial modelling, performance metrics, KPIs, venture borrowing, Series A equity funding, ERP system implementation, international business operations, and acquisition due diligence and integration. Before joining Ideanomics, Mr. McCarthy most recently held a CFO position at OS33. Prior to that, he was CFO for Intent Media Inc.

Kate Lam is the company’s Managing Director of Financial Products. She is highly regarded for her fixed income capital marketing skills across Asia and the United States. Ms. Lam has over 25 years of experience in the financial markets industry, dealing with many asset classes and clients. Having spent a few years in the fintech startup industry, her skills bridge the gap between traditional financial assets and new technological innovations. She has held senior management positions at Bear Sterns, Deutsche Bank and Standard Chartered Bank.

Keith Byers is Ideanomics’ Senior Vice President of Operations. He has extensive experience managing strategic relationships with key clients and deepening the relationships through innovation and successful engagement strategies. Before Ideanomics, Mr. Byers was the Managing Partner and Head of Operations for Gain Theory. He has a Master of Arts – MA, Economics from Heriot-Watt University and a Master of Science – Economics from The University of Edinburgh.

Tony Sklar is the company’s Senior Vice President of Investor Relations. He is a communication strategist and has worked for multi-faceted companies with global operations. Mr. Sklar handles omni-channel distribution using intelligence platforms and data insights for strategic planning, international expansion and marketing channels. His specialties include project management with digital strategy and transformation, ICO, marketing, blockchain and strategic partnerships. In addition to his role with Ideanomics, he is also a board member for the Delaware Board of Trade and the host and senior technology reporter for Far From TV.

Ideanomics Inc. (IDEX), closed Thursday’s trading session at $2.37, off by 5.20%, on 15,851,542 volume. The average volume for the last 3 months is 23,582,934 and the stock's 52-week low/high is $0.370000004/$5.5300002.

Recent News

Uranium Energy Corp. (NYSE American: UEC)

The QualityStocks Daily Newsletter would like to spotlight Uranium Energy Corp. (NYSE American: UEC).

Uranium Energy (NYSE American: UEC) is intent on advancing and expanding Burke Hollow’s resources, an in-situ recovery (“ISR”) uranium project in South Texas, according to a recent article. As a result, it “restarted wellfield development and resource delineation drilling.” The expansion of Burke Hollow’s resources “dovetails with UEC’s plans to participate in supplying the U.S. Uranium Reserve (‘UR’) as outlined in the Nuclear Fuel Working Group report published by the U.S. Department of Energy.” The company controls the largest uranium resource base of fully permitted ISR projects in Texas and Wyoming of any U.S.-based producer and is also “investing to build the next generation of low-cost and environmentally friendly uranium projects that will be competitive on a global basis.” These various exploits are geared towards fulfilling a specific objective, as CEO Amir Adnani noted: “Our main objective is to continue adding value to our shareholders and grow the company into the largest and most profitable uranium company in the United States.” To view the full article, visit https://ibn.fm/wHA4D

Uranium Energy Corp. (NYSE American: UEC) is a U.S.-based uranium mining and exploration company that controls one of the country’s largest historical uranium exploration and development databases. Founded in 2003, UEC is headquartered in Corpus Christi, Texas. Properties acquired by the company are primarily located within the United States, including Texas, New Mexico, Colorado, Arizona and Wyoming.

Through the use of historical exploration data, UEC has been able to target and acquire properties that have already been subject to exploration and development by senior energy firms in the past.

UEC is well-financed to aggressively pursue key developmental targets. The company is also well-positioned to capitalize on rising global demand for more uranium and more carbon-free energy, and it uses technology that contributes to a cleaner environment.

In-Situ Recovery (ISR) Technology

In-situ recovery (ISR) technology is a low-cost and environmentally friendly mining technology utilized by UEC at its fully licensed projects, including Palangana, Burke Hollow, Goliad and Reno Creek.

ISR technology involves the circulation of naturally occurring and benign groundwater through a uranium ore body. This natural water (that is unfit for any other use) plus oxygen is pumped into injection wells through the uranium ore body, where the uranium in the host sandstone is oxidized and solubilized. The uranium bearing groundwater continues to flow through the sandstone to the extraction wells, where it is pumped to the surface. This water proceeds to an ion exchange unit (like a big water-softener) for uranium removal, then is pumped back to the wellfield and again re-circulated through the ore body. This recirculation of the same groundwater continues over and over, until the uranium in the sandstone is depleted.

In the ion exchange process, the extracted uranium in solution is concentrated on resin beads for transport to the Hobson Processing Facility. There, the uranium then undergoes several simple processing steps before being dried and packaged as “yellowcake” that will be transported to a conversion facility, where its sold to UEC customers.

Hobson Processing Plant

Hobson is the centerpiece in UEC’s hub and spoke production strategy, with low-cost satellite ISR operations all within relatively short trucking distance. The plant is fully licensed and currently on standby with an annual production capacity of 2 million pounds of U3O8. The spokes of the UEC strategy include the Palangana, Burke Hollow, Goliad, Salvo and Longhorn ISR projects. With an improvement in uranium prices that justify production, UEC plans to restart the plant with uranium loaded resins originating first from Palangana and then followed by Burke Hollow. UEC has applied for a license amendment with the Texas Commission on Environmental Quality to increase the Hobson facility’s production capacity to 4 million pounds per year.

Current Projects

Uranium Energy’s current project portfolio includes:

  • Texas – Hobson Processing Plant, Palangana Mine, Goliad, Burke Hollow, Salvo and Longhorn
  • Wyoming – Reno Creek
  • Paraguay – Oviedo, Yuty and Alto Paraná
  • New Mexico – Dalton Pass and C de Baca
  • Colorado – Long Park and Slick Rock
  • Arizona – Anderson, Los Cuatros and Workman Creek
  • Canada – Diabase

Uranium Market Outlook

The long-term fundamentals underlying the market continue to strengthen. Currently, UEC sees an annual gap of about 40 million pounds between uranium production and utility requirements. Current forecasts show this structural deficit persisting at least through 2026 and then expanding further to almost 70 million pounds per year by 2030. While secondary supplies have been filling the void, those supplies are not a sustainable long term supply source. There are different estimates on timing, but it is clear secondary supply (that includes inventory drawdowns) will be insufficient to fill the projected gap between supply and demand, and new production will be required. As this transition evolves, the market will become more production cost driven as opposed to inventory driven.

Higher priced contracts that have supported high production costs are continuing to roll out of producer and utility supply portfolios. These higher priced contracts are not replaceable, with current market prices below production costs for the vast majority of western producers. This will likely continue the trend of production cuts and deferrals until prices rise sufficiently to sustain long-term mining operations.

In the U.S., some of the foreign State-Owned Enterprise (“SOE”) supply that has been flooding the market will be reduced. Last year, the U.S. Department of Commerce negotiated an amendment to the Agreement Suspending the Antidumping Investigation on Uranium from the Russian Federation that reduces America’s dependence on Russian natural uranium concentrates by up to 75% from prior levels. Due to a prolonged weak pricing environment from an influx of price insensitive supply from SOEs, U.S. production is effectively zero, less than 1% of U.S. requirements.

On the demand side of the equation, further upside market pressure also appears likely to evolve as utilities return to a longer-term contracting cycle to replace expiring contracts. Over the longer term, there continues to be underlying and increasing demand building, as the globe continues a push toward carbon-free energy goals. Those goals will require the 24/7, base load, clean energy that nuclear power provides as part of the overall supply mix. A good example of that policy messaging came from Japan’s energy minister, who recently said he considers nuclear energy “indispensable” if the country is to meet its net-zero carbon emission goals.

Exacerbating the overall supply picture, lead times for new production typically range from seven to 10 years or longer. The market appears to be within the time frames required for investment to bring new supply online to meet those lead times. However, prices are not yet at levels that incentivize future production, increasing the probability of the potential for less supply than the market is currently pricing in. All things considered, UEC believes the supply and demand fundamentals should continue to exert upward pressure on uranium prices.

Management Team

Spencer Abraham is Chairman of the Board for UEC. He served as the 10th U.S. Secretary of Energy from 2001 to 2005. He is an honors graduate of Michigan State University and Harvard Law School, and he was a law professor at the Thomas M. Cooley School of Law. He was elected chairman of the Michigan Republican Party in 1983 and later served as deputy chief of staff in the office of the vice president and as co-chairman of the National Republican Congressional Committee. In 1994, Mr. Abraham was elected to the United States Senate from Michigan and has also served as a director of Occidental Petroleum and as the non-executive chairman of AREVA’s U.S. board.

Amir Adnani is the Chief Executive Officer, President and Director of Uranium Energy. He advanced the company from concept to United States production within its first five years. Mr. Adnani has developed an extensive pipeline of low-cost and near-term production projects. He is the founder and Chairman of GoldMining Inc. (TSX: GOLD) (OTCQX: GLDLF), a gold-resources acquisition and development firm. He is also the Chairman of Uranium Royalty Corp. (TSX.V: URC). Mr. Adnani holds a Bachelor of Science from the University of British Columbia. He is a director of the University’s Alumni Association.

Scott Melbye is the company’s Executive Vice President. He is a 36-year veteran of the nuclear energy industry and has held numerous leadership positions in major uranium mining firms. He is also the current President, CEO and Director of Uranium Royalty Corp. He is an advisor to the Nuclear Energy Program at the Colorado School of Mines. Prior to his work at Uranium Participation Corp., Mr. Melbye worked for Cameco Inc. for 22 years. He received a Bachelor of Science in Business Administration with a specialization in International Business from Arizona State University in 1984.

Bruce Nicholson is the company’s Vice President of Corporate Development. He has spent 16 years as a specialist in the industry, serving major United States and European banks, broker-dealers and investment funds. Mr. Nicholson is a member of the Minerals Economics and Management Society, Minerals Industry Analyst Group, and the New York Society of Securities Analysts. He graduated with an MBA in Finance from Rutgers University in 1995 and is a CFA charter holder.

Uranium Energy Corp. (UEC), closed Thursday’s trading session at $2.70, off by 2.5271%, on 6,255,923 volume. The average volume for the last 3 months is 7,126,354 and the stock's 52-week low/high is $0.819999992/$3.67000007.

Recent News

Gage Cannabis Co. (CSE: GAGE)

The QualityStocks Daily Newsletter would like to spotlight Gage Cannabis Co. (CSE: GAGE).

Gage Growth Corp. (CSE: GAGE) (d.b.a. Gage Cannabis) was featured today in the 420 with CNW by CannabisNewsWire. Minnesota, home to one of the strictest medical cannabis programs in the country, is one step closer to an adult-use market. For the first time ever, a bill that would legalize recreational cannabis and expunge minor cannabis convictions has advanced far into the legislature and is expected to receive a full floor vote in the Minnesota House during its final hearing this week. The bill, which was authored by Democratic House Leader Ryan Winkler of Golden Valley, has been through a dozen hearings so far and is especially focused on criminal justice.

Gage Cannabis Co. (CSE: GAGE) is a leading vertically integrated operator in the cannabis industry led by the former CEO and Chairman of Canopy Growth Corp. (TSX: WEED) (NYSE: CGC), Bruce Linton. The company is currently focused exclusively on the Michigan market, working with the declared goal of building the fastest growing cannabis brand in the state.

One of the reasons Gage targeted Michigan as its location of choice is due to the state’s fast-growing legal cannabis market and consumption habits amongst consumers. In 2018, Michigan became the 10th state to legalize the recreational use of cannabis. In light of such favorable market dynamics, Gage opened its first medical provisioning center (dispensary) shortly after, in 2019. The company now has 13 medical or adult-use locations open or in the works, with an additional 10+ planned to open during 2021. Gage’s current portfolio features 19 Class C cultivation licenses across four cultivation assets and three processing licenses.

Current Asset and Brand Portfolio

Gage’s current brand portfolio consists of five unique product classes: flower products, edibles, hardware, concentrates and vape pens/disposables.

The company has already created relationships with a wealth of exclusive brand partners, including some of the most illustrious brands in the country. Notably, Gage’s exclusive partnership with Cookies, one of the most well-respected cannabis lifestyle brands in the United States, illustrates Gage’s operational prowess in cultivating quality flower and operating its branded retail stores. Today, Gage operates the 8 Mile Cookies location in Detroit, Michigan, which is one of the top performing dispensaries in the state despite being a medical-only dispensary.

Committed to providing only products of the highest quality, Gage uses small-batch, indoor-grown, high-quality cannabis that is hand-trimmed and hung to dry. Gage ensures that every gram of cannabis sold is consistently of the highest quality and offers a superb customer experience.

The company currently has four cultivation assets, located at Monitor Township (expansion planned), Harrison Township, Warren and Lenox Township, and it operates one processing facility located in Harrison Township, with plans to operate another two processing facilities in Monitor Township and Lenox.

Its operating dispensaries include Ferndale (adult-use), Adrian (adult-use), Lansing (adult-use), Traverse City (medical) and Detroit (Cookies establishment – medical). Additional dispensaries coming soon include Battle Creek (adult-use), Kalamazoo #1 (adult-use), Bay City (adult-use), Grand Rapids (medical), Buena Vista (medical), Center Line (medical), Kalamazoo #2 (Cookies establishment – adult-use) and Lenox Township.

The company offers delivery within a one-hour radius of its dispensaries – a footprint that encompasses an estimated 90% of Michigan’s population.

Financial Highlights

In Q1 2020, the company recorded sales of $5.8 million. This number grew substantially in Q2, reaching $11.9 million. Management estimates Q3 sales at roughly $13.1 million, marking a 157% growth in sales from January to September 2020, within a year of operations.

This increase reflects the company’s significant expansion efforts since the beginning of 2020. Starting with only 200 pounds per month, Gage now estimates its monthly cultivation capacity at more than 1,000 pounds of product.

This increase in cultivation capacity has helped Gage promote rapid growth through its retail locations. Average basket size, which refers to the retail value of each consumer transaction, is estimated at $85 for the Michigan cannabis industry. As of August 2020, Gage has an average basket size of $180 at its locations, more than double the state average.

Michigan Medical and Adult-Use Marijuana Market Size

The recreational marijuana market in Michigan is expected to rival the numbers currently seen in Nevada and Colorado by 2023. Approximately 3% of Michigan’s residents are medical marijuana cardholders – a much higher rate than many other medical markets – leading Brightfield to predict that the state’s recreational market could triple in size between 2020 and 2023 (https://ibn.fm/9cO0h).

Michigan saw a steady increase in sales for the first three quarters of 2020, with a recorded growth rate of 502% from January to August. In August alone, $109 million in cannabis sales occurred within the state. The Marijuana Regulatory Agency estimates that the potential market size for cannabis within the state is around $3 billion.

Neither Gage nor the state has seen any significant drop in sales in the wake of the COVID-19 pandemic. On the contrary, demand has continued to grow steadily, as dispensaries were among the few businesses deemed essential and permitted to operate throughout the shutdown. All Gage and Cookies locations have remained operational, offering curbside pickup.

Management Team

Bruce Linton is the Executive Chairman of Gage Cannabis. He joined the company in 2019 and is the founder and former CEO and Chairman of Canopy Growth Corp. (TSX: WEED) (NYSE: CGC). Mr. Linton has extensive executive and board experience in a variety of industries and is considered to be a pioneer in the global cannabis industry. He provides incomparable support to the company’s strategic and capital markets efforts.

Michael Hermiz is the Co-Founder and Director of Gage Cannabis, and he is also the founder of a federally licensed producer in Canada. Mr. Hermiz has had great success in various industries, including real estate, mortgage, telecommunications, import, export and many others.

Fabian Monaco is Gage’s President and Director. He previously worked at XIB Financial Inc., GMP Securities L.P. and Scotiabank. In addition to his vast investment banking and legal background, Mr. Monaco has 10+ years of capital markets experience. His advisory experience in the cannabis industry is also extensive.

Dr. Rana Harb is a Director of Gage Cannabis. She has 25+ years of experience handling research, compliance, quality assurance and regulatory affairs. A significant portion of her regulatory and compliance history is in the cannabis industry. Dr. Harb has worked for many pharmaceutical companies worldwide, dealing with regulatory agencies such as the FDA, the EMA and Health Canada.

Mike Finos is the President (USA) and a Director of Gage Cannabis. He is the former COO of Horizon Global, the world’s number one towing accessories company. He has experience with start-ups, M&A and business integration with both private and publicly traded companies. With 20+ years of operational leadership expertise, Mr. Finos has extensive knowledge relating to supply chain logistics, manufacturing and information technology.

David Watza is the Chief Financial Officer of Gage Cannabis. He is an experienced C-Suite executive and former CFO and board member of Perceptron Inc. (NASDAQ: PRCP). Mr. Watza has 30+ years of experience in finance, accounting, and operations, including time as a public company CFO.

Gage Cannabis Co. (CSE: GAGE), closed Thursday’s trading session at $2.20, off by 1.79%. The average volume for the last 3 months is 475,121.

Recent News

Splash Beverage Group Inc. (OTCQB: SBEV)

The QualityStocks Daily Newsletter would like to spotlight Splash Beverage Group Inc. (OTCQB: SBEV).

Splash Beverage (OTCQB: SBEV), a holding company with a leading portfolio of beverage brands, announced that it has file its Q1 2021 Report for the period ending March 31, 2021. Highlights of the report include the company’s quarter-over-quarter sales growth and increase in cash equivalents. The company reported that it had cash and cash equivalents totaling $1,225,406, compared to $380,000 on Dec. 31, 2020. The report noted that the increase is primarily due to cash received from SBEV’s PPM, an offering comprised of 3,636,364 shares of common stock at a purchase price of $1.10 per share resulting in total gross proceeds of $4 million. In addition, the report showed year-over-year sales growth with revenue for Q1 reaching $2,417,701 compared to revenues of $112,003 for the same quarter in 2020. The report tied the increase to growth within Qplash, the company’s vertically integrated B2B and B2C e-commerce distribution platform, which sells goods on both Amazon and Shopify; the report also noted the company’s increased sales from its single-serve wine business. The company also announced that its successful capital raise, completed in February 2021 and totaling an estimated $9 million, opens the door for new opportunities and closes the door on the ability for to convert equity to debt. To view the full press release, visit https://ibn.fm/BDe6F. Also, the company was highlighted in a publication from Wall Street PR, examining how growth stocks have been taking heat over recent days as interest rates pick up amid a sudden scramble following some less than positive inflation readings. However, the larger bull market trend remains intact, suggesting this pullback could be an important opportunity to put new money to work.

Splash Beverage Group Inc. (OTCQB: SBEV) is a portfolio company of successful beverage brands with the objective of driving value through superior production, supply chain efficiency and global distribution capabilities.

Specializing in manufacturing, distributing, sales & marketing of various beverages across multiple channels, the company operates in both the alcoholic and non-alcoholic beverage segments, allowing it to leverage efficiencies and dilute risk. The company’s business strategy is to quickly develop and/or accelerate pre-existing brands to exit for cash events. Led by a highly successful management team, the company only works with brands it perceives to have highly visible preexisting brand awareness or pure category innovation, thus breaking through the clutter. Splash seeks out brands offering products that:

  • Deliver natural quality, health benefits, freshness and refreshment within their beverages;
  • Are on trend with consumers;
  • Have a high level of brand awareness;
  • Maintain highest performance standards and focus on execution;
  • Help distributors and retail partners achieve and exceed all goals; and
  • Offer unapologetic support for members of the U.S. armed forces, first responders and health care professionals.

Splash was founded in 2013 and is located in Fort Lauderdale, Florida.

Splash Portfolio

The current Splash portfolio includes four unique beverage brands. Each of these brands offers one or more of the qualities that the company specifically seeks in an acquisition.

  • TapouT Performance is a natural isotonic hydration & recovery sport drink featuring a 3-in-1 advanced formula. TapouT Performance restores what the body loses through physical exertion, delivering hydration and cellular recovery. Perfectly balanced with key vitamins & minerals and all five necessary electrolytes, TapouT increases nutrient absorption, allowing the body to recover quickly and more efficiently. TapouT is the official training partner of the WWE (NYSE: WWE).
  • Salt Naturally Flavored Tequila is a 100% blanco agave 80 proof tequila that offers a clean and delicate taste. Salt is grown, distilled and bottled in the Jalisco region of Mexico. Every bottle of Salt Tequila is the result of hard work, determination and numerous blends. The brand offers a line of tequila flavors for enhanced refreshment, including berry, citrus and salted chocolate.
  • Copa Di Vino is the leading producer of premium “wine by the glass” in the U.S. Produced in the Columbia Valley, Copa di Vino is readily available on the go without the requirement of a bottle, corkscrew or glass. Open, drink and enjoy.
  • Pulpoloco Sangria is a premium crafted sangria imported from Spain. Its flavor is light-bodied, fruity and refreshing, offering the best blend of Spanish ingredients. The product is filled and packed in a unique eco-friendly biodegradable catocan, allowing Pulpoloco to extend the shelf life of the sangria without the use of preservatives.

Market Outlook

The global beverage industry was valued at $1.5 trillion in 2018 and is projected to grow at a CAGR of 3.1%, reaching a market size of $1.9 trillion by 2024 (https://nnw.fm/w1Cx9). The push for non-alcoholic beverages that are healthier and contain zero sugar is expected to be a driving force in the forecast period and beyond.

With a seasoned management team and sufficient capital to fuel sustained growth, Splash is uniquely positioned to capitalize on this market growth. The company is currently preparing a secondary offering and has engaged Kingswood Capital Markets as lead underwriter in order to uplist to the Nasdaq or NYSE in the near future.

Management Team

Robert Nistico is the Chairman and CEO of Splash Beverage Group. He has 28 years of experience in the beverage industry and was the fifth employee and SVP/General Manager of Red Bull North America. In this role, he led the start-up from zero sales to $1.65 billion in annual sales. Mr. Nistico was a founder and President of Marley Beverages and was responsible for framing the company’s long-term vision. Mr. Nistico held executive positions at DIAGEO, Republic National Distributing Company and the Gallo Wine Company resulting in decades of successful experience in the ‘Three Tier Beverage System’. In the spirit of his true entrepreneurial nature, he is a motivated, results-driven, creative and passionate leader.

William Meissner is the company’s President and CMO. He boasts over 20 years of success in growing consumer brand companies with large and medium-sized entrepreneurial organizations, both locally and internationally. His résumé includes multiple CEO roles, leading efforts to revamp both healthy and distressed companies. Before joining Splash, Mr. Meissner was the President and CEO of Sweet Leaf and Tradewinds Tea. He has held multiple positions with leading companies in the beverage sector, including Sparkling Ice, Jones Soda, SoBe Beverages, Fuze & NOS (Coca-Cola) and many others.

Sanjeev Javia is the Vice President of Product Development for Splash. He is the founder and President of Javia Wellness Group, a firm focusing on the innovation, research, formulation and design of healthy exercise and wellness initiatives. Mr. Javia is a sports nutrition expert, allowing him the advantage of developing innovative functional beverages that include health benefits for consumers. Since 2000, he has advised and written nutritional plans for hundreds of the world’s most famous athletes, including Tom Brady, Kurt Warner, Curt Schilling and more.

Dean Huge is the company’s Chief Financial Officer. He brings 35 years of public and private sector accounting and finance experience to the Splash Beverage team. Mr. Huge has led four public offerings as CFO and guided the growth efforts of numerous companies, including Catalyst Energy Corp., which was named Inc. Magazine’s ‘Fastest Growing Company’ within 36 months of his joining. His expertise spans financial services, manufacturing, distribution and SAAS-type programs.

Aida Aragon is the company’s Senior Vice President of National Accounts. She is a sales, marketing and brand management executive with years of experience working in the sports supplement and beverage industry. In her previous positions, Ms. Aragon was vital in leading successful store rollouts for brands including Muscle Milk. Her passion for brand development comes as second nature, but her true passion has always been focused on increasing sales for brands in the sports nutrition industry.

Splash Beverage Group Inc. (SBEV), closed Thursday’s trading session at $1.97, off by 6.1234%, on 44,603 volume. The average volume for the last 3 months is 49,895 and the stock's 52-week low/high is $0.210299998/$5.0999999.

Recent News

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT)

The QualityStocks Daily Newsletter would like to spotlight XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT).

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator at the leading-edge of the life science industry,released an update on its 2021 drug formulation programs, noting that the programs are advancing on schedule and expanding in scope. The company’s Rotigotine transdermal human pilot study was successfully completed in March and the program now advancing to a pivotal study stage; the pilot study evaluated the use of the Rotigotine transdermal patch in the treatment for Parkinson's disease. In addition, the update noted that XPhyto had purchased land in Germany for the construction of its commercial drug manufacturing facility in Germany. The company's drug formulation and development projects are conducted primarily by XPhyto’s wholly owned German subsidiary, Vektor Pharma TF GmbH, a company focused on the development of generic and hybrid-generic drug formulations for neurological conditions through its transdermal and oral dissolvable drug delivery platforms. "Vektor continues to build shareholder value by advancing its product development pipeline,” said XPhyto CEO & Director Hugh Rogers in the press release. “Its lead program is now progressing to a pivotal human study in Europe, which is the final major milestone on the path to commercial regulatory approval. The addition of in-house, scalable commercial drug manufacturing capability is expected to add further value and optionality to XPhyto's drug formulation and manufacturing businesses." To view the full press release, visit Also today, the company was featured in a publication from BioMedWire, examining how a study conducted by researchers from Baylor College of Medicine has found that intermittent fasting (“IF”) has the potential to decrease hypertension by restructuring gut microbiome. Hypertension increases an individual’s risk for getting a stroke or cardiovascular ailments, which are the major causes of death within the United States.

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) is a bioscience accelerator focused on next-generation drug delivery, diagnostic and new active pharmaceutical ingredient investment opportunities. This includes products that are being readied for commercialization within the coming weeks, such as a rapid COVID-19 PCR test kit that reduces turnaround times to less than 30 minutes.

The company has research and development operations in North America and Europe and an operational focus in Germany. Its regulatory approval and commercialization focus is currently on products for the European market.

XPhyto was founded in 2017 and is headquartered in Vancouver, British Columbia.

Business Strategy & Milestones for 2021

On January 18, 2021, XPhyto issued a news release detailing its business strategy for the coming year. The company noted that it is “on the cusp of transformational change as product development programs advance from the laboratory to the clinic.” In addition to continuing to leverage its scientific expertise and operations in North America and Europe for product development and optimization, XPhyto intends to pursue growth through the commercialization of existing products and adherence to a focused investment strategy targeting impact-driven innovation with “the potential for extreme value creation.”

In particular, XPhyto is well positioned to execute on opportunities across its current business divisions, including:

  • Commercialization of infectious disease diagnostics
  • Clinical validation of transdermal and sublingual drug formulations
  • Continued investment and development in psychedelic medicine

“2020 was a very productive year for XPhyto. We made significant progress in all areas of our business,” Hugh Rogers, CEO & Director of XPhyto, stated in the update. “We have ambitious milestones for 2021 with multiple product launches on the horizon, multiple clinical drug programs underway, and an aggressive commitment to psychedelic medicine. I am extremely confident that our team can execute on the company’s business plan for 2021.”

Infectious Disease Diagnostics

XPhyto’s lead diagnostic product, secured through an exclusive global commercialization agreement with 3a-diagnostics GmbH (“3a”), is a rapid and highly portable PCR diagnostic test. Notably, PCR testing “has emerged as the only internationally recognized standard for COVID-19 testing” and is expected to play a key role in facilitating the recovery of the domestic and international travel industries, among others.

Successful validation of the PCR system was achieved in Q4 2020, and XPhyto has expressed confidence that it will achieve European commercial (CE-IVD) approval in Q1 2021. In preparation for this milestone and an anticipated Q1 product launch, the company is currently in discussion with manufacturing and distribution partners in Europe and the Middle East.

In addition to COVID-19 products, XPhyto and partner 3a are developing and commercializing a portfolio of low-cost oral biosensors. The company’s lead biosensor product is an oral health screening test for the detection of peri-implantitis for which XPhyto is targeting a late 2021 European commercial approval.

XPhyto does not make any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 pandemic.

Drug Formulation & Delivery

In 2020, XPhyto’s German subsidiary, Vektor Pharma TF GmbH (“Vektor”), reported significant advancement in four therapeutic programs targeting neurological indications with significant market demand. Vektor also successfully developed a sublingual drug formulation on contract for a major generic drug manufacturer and distributor.

XPhyto will look to build on this progress in 2021, with plans to complete human pilot studies evaluating its four lead therapeutic products:

  • Rotigotine transdermal patch for Parkinson’s disease
  • CBD oral/sublingual strip for treatment resistant epilepsy
  • THC oral/sublingual strip for anorexia/nausea
  • CBD:THC (1:1) oral/sublingual strip for multiple sclerosis associated spasticity

Per its 2021 business update, the company is currently in “ongoing discussions with multiple potential commercial partners, licensors and distributors and will be reviewing monetization opportunities on a continued basis.”

Psychedelic Medicine

Psychedelic compounds are a highly promising new class of active pharmaceutical ingredient (“API”) demonstrating strong potential for a variety of mental health conditions. XPhyto is positioned to capitalize on this promise through two strategic initiatives:

  • An agreement for the development of industrial scale biotechnology processes for the production of psilocybin
  • An agreement for R&D related to multiple psychedelic compounds, including psilocybin, mescaline, LSD, MDMA and DMT, among others

XPhyto intends to advance and expand its programs focused on the industrial scale production of psychedelic API in 2021. The company also plans to launch new programs for the development of psychedelic drug formulations, with a focus on sublingual and transdermal therapeutics and the integration of these products into established clinical programs relating to mental health indications.

Management Team

Hugh Rogers is the CEO and Director of XPhyto Therapeutics Corp. He is an entrepreneur and lawyer with private and public start-up company experience in various industries and operational roles. His recent advisory work has focused on public listings and corporate restructuring. This restructuring has occurred in the life science (cell therapy and medical device) and natural resources (natural gas co-gen and conventional oil) industries. Mr. Rogers holds a bachelor’s degree in Cellular Biology and Genetics and a law degree. He is a member in good standing of the Law Society of British Colombia.

Christopher Ross is the CFO of XPhyto. He is a professional accountant with broad financial experience across numerous industries, including forestry, distribution, construction, mining and multi-family real estate. He has provided advisory services to private and public companies in the areas of financial accounting, strategic analysis, audit and taxation. Mr. Ross holds a bachelor’s degree in commerce. He is a member in good standing with the Chartered Professional Accountants Association of British Columbia.

Wolfgang Probst serves as Director of XPhyto and Managing Director of BUNKER Pflanzenextrakte GmbH. He is a seasoned management and financial consultant based in Bavaria, Germany. He has consulting experience as branch head working with private clients and corporations of high net worth. In 2017, Mr. Probst assumed the CFO role of BUNKER and continues to play a key role in its operational and financial development.

Professor Dr. Raimar Löbenberg serves as Director of XPhyto. He holds a Bachelor of Science in pharmacy from Johannes Gutenberg-University and a Ph.D. in pharmaceutics from the Johann Wolfgang Goethe-University. He is the co-founder of RS Therapeutics Inc., which concentrates on foam-based topical drug delivery systems.

Professor Dr. Thomas Beckert is the Founder and Managing Director of Vektor Pharma TF GmbH. His expertise includes the formulation and machine development of transdermal therapeutic systems and ODFs. Professor Beckert holds a Bachelor of Science in pharmacy from the University of Freiburg and a Ph.D. in pharmacy and economics from the University of Tubingen.

XPhyto Therapeutics Corp. (OTCQB: XPHYF), closed Thursday’s trading session at $1.7889, off by 1.9781%, on 44,322 volume. The average volume for the last 3 months is 73,787 and the stock's 52-week low/high is $1.3125/$3.0999999.

Recent News

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF)

The QualityStocks Daily Newsletter would like to spotlight PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF).

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 50+ trusted brands within the InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities. To view the full publication, “Cooking Up a Winning Recipe to Capitalize on $74 Billion Plant-Based Food Market,” please visit: https://nnw.fm/ObpVz.

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) aims to redefine the plant-based community through e-commerce, with a core objective of becoming the most trusted and convenient destination for people living plant-based lives. PlantX is a multifaceted marketplace providing consumers all things plant-based ranging from an efficient e-commerce experience, connecting consumers with interactive PlantX brick-and-mortar stores, and a PlantX home delivery system for products, meals, recipes and more.

PlantX is a high-growth technology company focusing on consumer-packaged goods (“CPG”) for the plant-based opportunity. The PlantX platform aims to serve as the digital face of this community with its one-stop-shop for everything plant-based, including:

  • An easy-to-use e-commerce shopping experience featuring the following:
    • Plant-based grocery items (from all your pantry needs to vitamins, cosmetics and even pet food)
    • Meal delivery with recipes created by well-known plant-based chefs throughout the world
    • Plant shop – delivering a wide variety of affordable indoor houseplants to homes across Canada and the U.S.
    • Easy to follow plant-based recipes every week
    • Partnerships with restaurants, nutritionists, chefs and brands
    • A community of like-minded individuals
  • State-of-the-art flagship PlantX locations

Since first launching in February 2020, PlantX Life has offered various services available through its comprehensive platform. This online marketplace features over 10,000 items across diverse product categories such as pantry items, beverages, personal care, pet food and indoor plants. In addition, PlantX has collaborated with renowned chefs and nutritionists to create 20 unique and pre-made meals delivered to the comfort of your own home.

Headquartered in Vancouver, Canada, PlantX’s mission is to spearhead the plant-based movement, celebrate and promote health and wellbeing, raise plant-based awareness in a hyper-palatable world, connect with global consumers and forge a welcoming plant-based community.

The company currently reports 4 million stock options and 24 million warrants outstanding, with a total of 88,832,159 shares issued and outstanding and a total market cap of $89.9 million on January 18, 2021. PlantX has continued to catalyze its capital markets dynamics by applying to list its common shares on the Nasdaq Capital Market (“NASDAQ”). The company’s common shares are eligible for electronic clearing and settlement through The Depository Trust Company (“DTC”) in the United States.

Market Outlook

With its comprehensive e-commerce platform, PlantX is strongly positioned for a prominent role in the fast-growing plant-based food market, e-commerce and the online food delivery sectors. The global plant-based food market is expected to reach $74.2 billion by 2027, expanding at a CAGR of 11.9%. Similarly, the online food delivery market has steadily grown, especially during the current pandemic. This trend seems here to stay. In the United States alone, the sector is expected to report $28.5 billion by 2024, with companies such as UberEats experiencing 152% increases in food deliveries in the summer of 2020.

Complementary to these trends, and as a result of the COVID-19 pandemic, online sales and digitization have also both grown exponentially in 2020. Grocery shopping has seen a remarkable transition to e-commerce, with online grocery sales growing by 53% in 2020. Amid the pandemic-imposed physical interactions and related consumer behavior change, large retailers have been compelled to meet this surge in e-commerce demand. For example, Whole Foods Markets has increased its online sales capacity by over 60% in 2020. The global meal kit delivery system is also becoming increasingly popular and is expected to achieve a market value of $19.92 billion by 2027, expanding at a CAGR of 12.8%.

PlantX aims to capitalize on this anticipated exponential market growth of the plant-based, e-commerce and home-delivery industries.

Digital Platform for the Plant-Based Community

The digital interface provided by PlantX spans a health and wellness initiative that offers thousands of plant-based products, meal delivery, indoor plants, recipes and a community space for those who are like-minded about plant-based products and healthy lifestyles. PlantX has been compared to Amazon, except with a focused tailored selection of plant-based offerings.

PlantX provides everything a consumer needs for plant-based living at the click of a button. With PlantX, customers can:

  • Shop
  • Find recipes
  • Read blogs
  • Join a community forum
  • Listen to podcasts
  • View cosmetics
  • Research vitamins
  • Purchase plant-based pet foods
  • Read corporate updates
  • Subscribe to an insightful newsletter

The company’s website was designed with a user-friendly interface that allows customers to visit the site and easily find what they need. Forums for communicating with a plant-based community make it easier to swap recipes or locate the best restaurants serving vegan and vegetarian-friendly cuisine.

PlantX Flagship Locations – British Columbia (Canada), San Diego (California), & the State of Israel

PlantX will link the e-commerce platform to flagship brick-and-mortar stores for a highly sensory customer experience. This is anticipated to drive corporate growth and global brand recognition.

These PlantX branded flagship locations will first launch in:

Customer engagement, education and creating a global plant-based community will be furthered through this initiative.

PlantX Restaurant Partnerships

With consumers becoming better informed and more health and environmentally conscious, a growing number of restaurants will start catering to the needs of customers who are vegan, vegetarian, have food-allergies (or specialized diets), or simply want to eat healthier.

PlantX proactively aims to support this change and help restaurants meet the needs of the plant-based community. Restaurants that want to increase revenue, drive traffic and make an impact can therefore partner with PlantX to better serve their customers by expanding and refining their menus.

Future Goals for PlantX Life

Having successfully completed all of the milestones that PlantX had set-out to achieve in the second half of 2020, PlantX strives to continue scaling through organic growth, strategic partnerships and accretive M&A opportunities. The upcoming plans from PlantX includes a global expansion strategy for distribution in North America, Europe and Israel.

Verticals launched in 2020 include:

  • New meals and programs by renowned chefs
  • Flagship PlantX locations
  • PlantX branded goods
  • United States meal delivery and LIV
  • Online peer-to-peer fitness

Management Team

Sean Dollinger, the Founder of PlantX Life Inc., has had a very active professional career that started when he was only 17. While still in college, he started a delivery service that soon became one of Canada’s largest delivery firms (before companies like Postmates and Uber Eats ever existed). In 2014, Mr. Dollinger founded Namaste Technologies, the largest international e-commerce distributor of vaporizers and accessories. He brought Namaste public and turned it into a $1.2 billion business in two years. After finding a plant-based diet himself, and seeing the massive benefits that it provided for him, he decided he wanted to find a way to give back to the community and focus on something he loves. PlantX Life was born from this desire and became his passion project. He truly walks the talk.

Julia Frank is the CEO of PlantX Life. She has an MBA in digital entrepreneurship, and, in her past roles, she set up renowned strategies for large corporations like BMW and Daimler in Germany. Beyond her professional business prowess, Ms. Frank finds tremendous joy in preparing delicious and nutritious plant-based meals and is the face of the company. She practices a healthy and active lifestyle that includes experiencing as many cultures as possible to add more knowledge of the industry at large. This globally inclusive perspective gives her the unique advantage of being able to see plant-based living from all angles.

Lorne Rapkin, CPA, CA, LPA, is the President and CFO of PlantX Life and is also a partner at Rapkin Wein LLP. He has experience with clients in almost every industry, including finance, professional services, real estate, automotive, media and manufacturing. Mr. Rapkin works very closely with investment and public firms, seeking to comply with IFRS accounting standards. His roles often require him to work with management on go-public transactions, acquisitions and mergers. His keen attention to detail is an asset to any client he works with, and PlantX is no exception.

Alex Hoffman is the company’s CMO and has spent the last 10 years in the creative field cultivating her passion for design and appreciation for beauty. This is apparent in all of the creative decisions and outcomes seen at PlantX. Her role within the company is to oversee all of the brand marketing activities, establish and execute key processes for rapid growth, and work closely with management to refine the brand’s message for key segments and emerging opportunities. She has a sharp vision for exactly what’s needed to convey the company’s core messages and principles to both the public and investors, and she is a visionary with respect to creative marketing ideas and concepts.

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF), closed Thursday’s trading session at $0.3925, off by 4.2683%, on 201,812 volume. The average volume for the last 3 months is 332,865 and the stock's 52-week low/high is $0.349999994/$1.85000002.

Recent News

Excellon Resources Inc. (TSX: EXN) (NYSE American: EXN) (FSE: E4X2)

The QualityStocks Daily Newsletter would like to spotlight Excellon Resources Inc. (TSX: EXN) (NYSE American: EXN) (FSE: E4X2).

If someone could do a flyby of the history of silver, they would cover the globe and witness annual production go from a few nuggets around 3,000 BCE to 800 million ounces in 2019 (https://ibn.fm/vofDl). From a time perspective, the majority of the journey would be spent throughout Europe where mining was integral to economies, empires and technical revolutions for centuries before Europeans landed in North American and silver production grew in Mexico. Germany, inclusive of the Rammelsberg Mine, where silver, copper and lead were mined continuously for over 1,000 years through 1988, was once a vibrant part of the industry; particularly after the Vikings had looted coastal Europe of most of its silver by 900 CE. Several contributing factors led to silver production all but disappearing in Germany today, although more days of Rammelsberg-like activity could lie ahead thanks to companies like Excellon Resources (TSX: EXN) (NYSE American: EXN) (FSE: E4X2) bringing modern technology to historically... To see the supporting images, visit https://ibn.fm/gHB6X. Also, the company was pleased to report financial results for the three-month period ended March 31, 2021 – as well as an update of the Mineral Resource Estimate for the Platosa Mine and a summary of the Company's consolidated mineral resources across all of its projects.

Excellon Resources Inc. (TSX: EXN) (NYSE American: EXN) (FSE: E4X2) (“Excellon” or the “Company”) is a silver and base metals producer with precious metal exploration and development projects in Mexico, Idaho and Germany. Since being founded in 1987, the Company has been advancing a precious metals growth pipeline focused on creating wealth for its stakeholders by realizing strategic opportunities in the silver and gold markets.

Excellon is an active and influential member of the Mining Association of Canada (“MAC”). The Company implements a practical, best-in-class management system that addresses the safety, health, security, environmental and community aspects of its operations, per the UN Sustainable Development Goals. On each project, the Company incorporates MAC’s Towards Sustainable Mining Initiatives and other world-class best practices with the objective of constantly improving its safety systems, training and hazard recognition.

Precious Metals Growth Pipeline

The Company is advancing a precious metals growth pipeline that includes: Platosa, Mexico’s highest-grade silver mine since production commenced in 2005; Kilgore, a high-quality gold development project in Idaho with strong economics and significant growth and discovery potential; and an option on Silver City, a high-grade epithermal silver district in Saxony, Germany, with 750 years of mining history and no modern exploration.

Maintaining and developing this pipeline presents the Company with enhanced opportunities in the expanding precious metals market, which was valued at $193.3 billion worldwide in 2020 (https://nnw.fm/6nv5f). This market is expected to increase at a compound annual growth rate (“CAGR”) of 9% from 2020 to 2027, resulting in an estimated $362.1 billion market size in 2027 (https://nnw.fm/6nv5f). Global market demand was calculated at 22,581.8 tons in 2020 and is expected to grow to 36,501.1 tons in 2027, achieving a CAGR of 3.5% (https://nnw.fm/6nv5f).

Excellon reported strong results in terms of both production and average pricing at the end of Q4 2020, including:

  • Silver – 355,581 oz – $24.46
  • Lead – 2,223,465 lbs. – $0.87
  • Zinc – 2,452,728 lbs. – $1.21

Compared to Q4 2019, Excellon’s silver production increased by 37%, lead increased by 32% and zinc increased by 19% in Q4 2020 (https://nnw.fm/4C0P7).

Platosa Mine – Silver, Lead, Zinc – Production, Development & Exploration

The Platosa Mine is located 5 km north of Bermejillo, Durango, Mexico, on a 14,000-hectare property. The mine commenced production in 2005 as an underground operation and is 100% owned and operated by Excellon. The Company is mining massive sulfide ores rich in silver, lead and zinc from a series flat-lying massive sulfide bodies (mantos) in a carbonate replacement deposit system. Historically, the mining method was a modified room and pillar method, which transitioned to cut-and-fill in recent years and overhand-cut-and-bench in 2020. The ore produced from the mine is transported 200 km south for processing at the Company’s 100% owned Miguel Auza mill.

Kilgore Project – Gold – Exploration & Resource Growth

The Kilgore Project is located in Clark County, situated in eastern Idaho in the United States. The project area is 100% owned and operated by Excellon. While still in the exploration and development phase, the primary target on the 13,627-acre site is an epithermal gold system. The property itself has historical mining that dates back to the 1930s, with modern mineral exploration beginning in the 1980s. The Kilgore Project displays characteristics similar to Kinross Gold’s Round Mountain Mine, which has produced more than 15 million ounces of gold since operations began in 1977.

Evolución Project – Mineral Processing, Resource Growth & Exploration

The Evolución Project is located in Miguel Auza, Zacatecas, Mexico, and hosts a large gold, silver, lead and zinc epithermal within a 45,000-hectare property that is 100% owned by Excellon. The site includes a processing facility with a mill and flotation circuit which processes ore from Excellon’s Platosa mine. The facility has a capacity of 800 tons per day, with a 650 ton-per-day ball mill in operation and a second 150 ton-per-day ball mill on standby. Excellon is looking at opportunities for toll milling, expansion and economic study of the mineral resource and grassroots exploration. Importantly, the project covers an unexplored 35-kilometer strike of the Fresnillo silver trend, the richest silver belt in the world.

Silver City Project – Exploration

Excellon holds an option to acquire the 16,400-hectare Silver City Project in Saxony, Germany. Initial drilling results in 2020 confirmed the presence of a high-grade, district-scale epithermal silver system over more than 12 kilometers of strike. The Company is now focused on defining wider zones of mineralization (https://nnw.fm/jMah9). Silver City was mined from the 11th to late-19th century, until Germany moved off the silver standard in 1873. The deposits in the area were exceptionally high grade, with historical records indicating grades well in excess of 1,000 g/t silver.

Oakley Project – Exploration

The Oakley Project, located in Oakley, Idaho, is an exploration project with land holdings of approximately 7,000 acres. The project hosts gold-silver, epithermal hot spring-type mineralization at two targets: Blue Hill Creek and Cold Creek, and detachment-related gold-silver mineralization at Matrix Creek. The Company has granted Centerra (U.S.) Inc. an option to earn in to a 70% interest by, among other things, spending up to US$7 million in exploration expenditures on the project prior to May 2026.

Management Team

Brendan Cahill is the President & Chief Executive Officer of Excellon Resources Inc. He was previously Vice President Corporate Development of Pelangio Exploration Inc., a junior gold exploration company active in Ghana, West Africa. Mr. Cahill is a board member of the Mining Association of Canada, Group Eleven Resources Ltd., and Kore Mining Inc. He holds a law degree from the University of Western Ontario and an undergraduate degree from the University of Toronto.

Alfred Colas is the Company’s Chief Financial Officer. Most recently, he held the title of CFO of Arch Corp., a Toronto-based private-equity investment firm. Mr. Colas has over 18 years of experience in the mining industry. He is a sitting board member for a housing corporation affiliated with the University of Toronto and is a Chartered Professional Accountant. Mr. Colas completed a Bachelor of Commerce at the University of Toronto.

Paul Keller is Excellon’s Chief Operating Officer. He has over 30 years of industry experience in mining and mine development operations. He previously served as the Senior VP of Major Projects and COO of Trevali Mining. He has experience in building mines from greenfield through permitting, design and operation. Mr. Keller holds a Bachelor of Engineering – Mining from Laurentian University.

Ben Pullinger is the Senior Vice President Geology & Corporate Development for Excellon. Ben brings over 15 years of experience in advancing projects from early stage exploration through to production. Most recently, he was Vice President Exploration at Roxgold Inc., where he made a significant contribution toward growing the 55 Zone at Yaramoko Project into a producing mine. Mr. Pullinger serves on the board of Orford Mining. He is a Professional Geologist (Ontario) and holds an Honors Degree in Geology from the University of Johannesburg.

Excellon Resources Inc. (EXN), closed Thursday’s trading session at $2.60, off by 1.5152%, on 64,292 volume. The average volume for the last 3 months is 50,585 and the stock's 52-week low/high is $2.19499993/$3.90000009.

Recent News

Sanwire Corp. (SNWR)

The QualityStocks Daily Newsletter would like to spotlight Sanwire Corp. (SNWR).

Sanwire (OTC: SNWR), a diversified company with a focus on technologies for the entertainment industry, has announced its new Label Portal, available through its 100% wholly owned subsidiary, Intercept Music Inc. The company also launched new marketing services designed specifically for independent artists and labels. Sanwire first introduced its Label Incubator program in February; the program is designed as an artist development suite of marketing and distribution services for labels wanting to enhance and strengthen the online footprint of their prospective artists as well as prepare their artists for recording contracts. To view the full press release, visit https://ibn.fm/6N8cn

Sanwire Corp. (SNWR) is a diversified company currently focused on technologies for the music industry. The company specializes in locating unique opportunities in fragmented markets and implementing its aggregated technologies to consolidate distinct services into unified platforms of delivery. Sanwire is currently focusing these efforts on advanced entertainment technologies.

Founded in 1997 and based out of Las Vegas, Nevada, Sanwire has operated and sold several subsidiaries as it has worked in various industry segments, including Sanwire Software Inc., Bullmoose Mines Ltd. and Squeeze Report Inc. Currently, there are two new holdings that were added to the company’s portfolio through two recent acquisitions, including Intercept Music Inc. in March 2020 and the Art is War Record Label in June 2020.

Intercept Music Inc. – Artist-Focused Services

Intercept Music Inc. is an entertainment technology company offering a unique suite of artist-focused services that are specifically designed to meet the needs of recording artists. Intercept’s proprietary online platform is dedicated to helping millions of global independent artists effectively promote their music and distribute it worldwide to hundreds of digital stores and every major streaming platform, including Spotify, Apple Music, Amazon Music, Pandora and Google Music.

With Intercept Music, recording artists have all the tools needed to market, promote and sell their music online and through social media. Comprehensive reporting allows artists to track the fan response to their releases, all the way down to individual music tracks.

There are three foundations of Intercept Music’s product offering:

  • Its music distribution platform that is well augmented via the company’s partnership with InGrooves, a wholly owned subsidiary of Universal Music, which is arguably one of the largest music companies in the world.
  • Its social media system, which is tailored to work the way artists use social media to promote their music and engage with their fans. The scheduling system integrates artists’ profiles across multiple social networking sites (Facebook, Twitter, Instagram and YouTube) to facilitate new audience sampling, fan development and the ability for music to be previewed and purchased.
  • The third is represented by the team of developers that brings a unique combination of deep technical expertise (in products like Skype), a team of well-accomplished executives and what the company calls Brand Ambassadors – senior reps from multiple genres who have helped artists earn over 100 Grammys.

Intercept Music is the confluence of technology and this music expertise.

The company currently markets three plans to its clients, with each offering different distribution and royalty options, as well as various marketing and reporting options. The plans are described below:

  • Intercept Distro is a basic plan for self-service music distribution with royalty collection. Artists keep 100% of the royalties while receiving unlimited releases and full analytics with reporting.
  • Intercept Artist includes all of the benefits of the basic Distro plan with added emphasis on social marketing and distribution for emerging artists. With this plan, artists receive scheduled and ad-hoc posting, social media reporting, reusable content libraries and access to other valuable features.
  • Intercept PLUS is available by invite only and is for established artists looking for a complete suite of marketing, distribution and monetization services. The PLUS plan includes everything available through the Distro and Artist plans, as well as offering a dedicated service representative, a branded online store, on-demand merchandise, additional marketing, YouTube monetization and other pro features.

Intercept PLUS is the flagship plan. Artists of this caliber often do $3-$10k/month in merchandise sales alone, at 50%+ profit. Intercept is responsible for marketing to the fan base through its social media system and shares in the profits generated. The stores are managed by intercept so both top-line revenues and bottom-line profits flow through Intercept.

Intercept Music has partnered with Ingrooves Music Group, the largest online music distribution company in the world, for worldwide distribution to streaming services and leading stores. Completing more than 50 billion transactions weekly across over 150 countries, Ingrooves supplies music to leading streaming music platforms and lists some of the world’s largest and most reputable music labels among its clients. The partnership allows Intercept Music and its clients to reach a much wider audience and start earning revenue as soon as possible by leveraging Ingrooves’ quality control systems and direct relationships with leading music streaming services.

Physical Distribution Options for Intercept Music Clients

In a press release on June 25, 2020, Intercept Music announced that it would be offering artists physical distribution through major retailers such as Amazon, FYE and Walmart (http://nnw.fm/NSrbE). The physical distribution will consist of CDs and vinyl and will serve as a supplement to the online streaming platform access provided by the company to represented artists.

“In the current climate, artists can’t play shows or otherwise engage in public at all, so they’re focusing on all other opportunities to bring in revenue,” Intercept Music President Tod Turner stated in a news release. “Our only priority is to help artists monetize music in every way, and with physical distribution added to the mix, we’re leaving no stone unturned in helping artists to earn money from their creative output.”

Creation of Preferred Stock

On June 29, 2020, Sanwire CEO Christopher Whitcomb announced that the company would be filing certificates of designation with the Nevada Secretary of State for its Series A, B and C preferred stock (http://nnw.fm/svrQt).

Speaking about this designation in a news release, Whitcomb stated, “Our paramount goal is to maintain a balanced approach between future investments and shareholder value while minimizing shareholder dilution. The effective utilization of preferred stock ensures our company can grow with the least amount of shareholder dilution.”

Sanwire is leveraging a multi-dimensional strategy that includes additional acquisitions, attracting investors and enhancing the current balance sheet while minimizing dilution for shareholders. A primary goal of these efforts is to support Intercept’s ongoing operations.

Financial Highlights

For the fiscal quarter ended June 30, 2020, Sanwire announced significant revenue growth related to the acquisitions of Intercept Music and Art is War Records. Since acquiring Intercept Music in March and Art is War Records in June, Sanwire’s revenue has increased by approximately 300% (http://nnw.fm/j0S0j). Sanwire attributes the increase in revenue to Intercept Music’s customer acquisition and the release of its PLUS plan.

For the third quarter, revenue is expected to continue an upward climb, owing largely to physical distribution plans and a rising number of PLUS subscribers. The company’s acquisition of Art is War Records is also expected to fuel this growth.

Management

Christopher M. Whitcomb is the current CEO of Sanwire Corp. and Intercept Music Inc. He is a CPA in the state of California, holding bachelor’s degrees in accounting, corporate finance and business management with a focus on real estate. A seasoned executive, his business ventures are always strongly focused on the development and financing of companies.

Whitcomb worked alongside Ralph Tashjian at SMC Entertainment Inc. and Digital Music Universe. They are currently working together again following Sanwire’s acquisition of Intercept Music, which was founded by Tashjian.

Sanwire Corp. (SNWR), closed Thursday’s trading session at $0.0103, off by 2.8302%, on 826,490 volume. The average volume for the last 3 months is 1,387,718 and the stock's 52-week low/high is $0.0035/$0.100000001.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

closed Monday's trading